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Abstract
The purpose of this study is to determine the way in which the demands set by
degree 423/2000 by the Ministry of Social Affairs and Health are fulfilled with
respect to the most radiosensitive groups, the foetus and the child, by
estimating the radiation dose and radiation risk to the foetus from x-ray
examinations of an expectant mother’s pelvic region, finding out the practice
involved in preventing doses to embryos and foetuses and assessing dose
practices in cases where an embryo or foetus is or shall be exposed, and by
estimating radiation dose and risk due to the radiation received by a newborn
being treated in a paediatric intensive care unit.
No statistics are available in Finland to indicate how many x-ray
examinations of the pelvic region and lower abdomen are made to pregnant
patients or to show the dose and risk to the foetus due these examinations. In
order to find out the practices in radiological departments concerning the
pelvic x-ray examination of fertile woman and the number of foetuses exposed,
a questionnaire was sent to all radiation safety officers responsible for the safe
use of radiation (n = 290). A total of 173 questionnaires were returned.
This study recorded the technique and Dose-Area Product of 118 chest
examinations of newborns in paediatric intensive care units. Entrance surface
doses and effective doses were calculated separately to each newborn. Based on
the patient records, the number of all x-ray examinations during the study was
calculated and the effective doses were estimated retrospectively to each child.
The radiation risk was estimated both for the foetuses and for the newborns.
According to this study, it is rare in Finland to expose a pregnant woman
to radiation. On the other hand, with the exception of pelvimetry examinations,
there are no compiled statistics concerning the number of pelvic x-ray
examinations of a pregnant woman. There was no common practice on how to
exclude the possibility of pregnancy. The dose to a foetus was not calculated
either before or after the pelvic x-ray examination of an expectant mother. The
responsibility for counselling an expectant mother about the risk of a radiation
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dose to the foetus was not determined. In conventional pelvic x-ray
examinations, the dose to the foetus varied from 1 to 2 mSv/exposure. A
proposal for a guide to good practices in the pelvic x-ray examination of women
of reproductive age is given.
The effective doses of 118 chest x-ray examinations to 43 newborns
(gestational age from 26 to 42 weeks) were estimated. The effective dose from
one chest radiograph varied from 7.5 µSv to 54 µSv. Retrospectively, the total
number of radiation examinations to these newborns totalled 399 during the
study; the mean was 9.3 (range 1–40). 98% of the examinations were produced
during the first treatment period after birth. The total effective dose per child
varied from 0.31 mSv to 3.7 mSv. The radiation risk of fatal childhood cancer
due to the mean dose of 0.37 mSv is 3.7·10 –5.
5STUK-A204
KETTUNEN Anja. Radiation Dose and Radiation Risk to Foetuses and
Newborns During X-ray Examinations. STUK-A204. Helsinki 2004, 155 s +
liitteet 19 s.
Avainsanat säteilyannos, säteilyriski, sikiö,  raskaus, vastasyntynyt,
efektiivinen annos
Tiivistelmä
Tämän tutkimuksen tarkoituksena on selvittää STM:n asetuksen 423/2000
vaatimusten  täyttymistä säteilyherkimpien ryhmien,  sikiön ja lasten osalta,
arvioimalla  sikiölle odottavan äidin lantion alueen röntgentutkimuksista
aiheutuva säteilyannos ja -riski, kartoittamalla käytäntö fertiilissä iässä
olevien naisten lantionalueen röntgentutkimusten suorittamisesta sekä
arvioimalla teho-osastolla hoidossa olevan vastasyntyneen säteilyannos ja
-riski.
Suomessa ei ole tilastoa raskaana oleville naisille tehdyistä  lantion ja
ala-vatsan alueen röntgentutkimuksista eikä sikiölle näistä  tutkimuksista
aiheutuneesta säteilyannoksesta tai -riskistä.  Fertiilissä iässä olevan, ala-
vatsan ja lantion alueen röntgentutkimukseen tulevan naisen raskauden
mahdollisuuden poissulkemiskäytännön ja säteilylle altistuneiden sikiöiden
määrän selvittämiseksi lähetettiin kyselylomake kaikille säteilyn käytöstä
vastaaville johtajille  (n=290). Kyselylomakkeita palautettiin 173.
Tässä tutkimuksessa selvitettiin tutkimustekniikka ja annoksen ja
pinta-alan tulo 118 lasten teho-osastoilla tehdyssä keuhkojen röntgen-
tutkimuksessa. Pinta-annos ja efektiivinen annos laskettiin erikseen jokaiselle
lapselle. Potilasasiakirjojen perusteella selvitettiin lapselle tehtyjen
röntgentutkimusten lukumäärä tutkimusjakson aikana. Efektiivinen annos
arvioitiin retrospektiivisesti jokaiselle lapselle. Säteilyriski arvioitiin sekä
sikiöille että vastasyntyneille.
Tämän tutkimuksen mukaan raskaana olevien naisten röntgen-
tutkimukset Suomessa ovat harvinaisia. Toisaalta, pelvimetriatutkimuksia
lukuun ottamatta, ei ole olemassa tilastoa raskaana olevien naisten lantion
alueen röntgentutkimusten lukumäärästä. Yhtenäistä käytäntöä raskauden
mahdollisuuden pois sulkemisesta ei ollut. Äidin lantion alueen röntgen-
tutkimuksesta sikiölle aiheutunutta säteilyannosta ei arvioitu ennen
röntgentutkimusta, eikä myöskään jälkikäteen. Kenellekään ei ollut
määritelty vastuuta informoida  odottavaa äitiä sikiölle aiheutuvasta säteily-
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riskistä. Tavanomaisessa lantion röntgentutkimuksessa sikiön annos vaihteli
välillä 1–2 mSv/tutkimus. Tässä tutkimuksessa annetaan ehdotus ohjeeksi
hyvästä käytännöstä fertiili-ikäisten naisten lantion alueen röntgen-
tutkimuksissa.
Efektiiviset annokset arvioitiin 118 keuhkotutkimuksesta, jotka oli
tehty 43 vastasyntyneelle (lapsi syntynyt 26–42 raskausviikolla). Efektiivinen
annos yhdestä keuhkotutkimuksesta vaihteli välillä 7,5 µSv–54 µSv. Näille
vastasyntyneille tehtiin tutkimusjakson aikana yhteensä 399 röntgen-
tutkimusta, keskiarvo oli 9,3 tutkimusta lasta kohden (vaihteluväli 1–40).
Tutkimuksista 98 % tehtiin ensimmäisen hoitojakson aikana syntymän
jälkeen. Efektiivinen kokonaisannos lasta kohden vaihteli välillä 0,31 mSv–
3,7 mSv. Keskimääräisestä efektiivisestä annoksesta (0,37 mSv) aiheutuva
lapsuuden aikainen syöpäriski on 3,7·10-5.
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Abbreviations
AEC Automatic Exposure Control
ALARA As Low As Reasonably Achievable
AP Anterior–posterior
BEIR Committee on the Biological Effects of ionising Radiation Board on
Radiation Effects Research Commission on Life Sciences National
Research Council
CEC Commission of the European Communities
CNS Central Nervous System
CT Computed Tomography
DAP Dose Area Product
ESD Entrance Surface Dose
FMRI Foetal magnetic resonance imaging
HUCH Helsinki University Central Hospital
ICRP International Commission on Radiological Protection
IQ Intelligence Quotient
LET Linear Energy Transfer
MED Council Directive 97/43/Euratom of 30 June 1997 on health
protection of individuals against the dangers of Ionising radiation
in relation to medical exposure
OR Odds Ratio
PCXMC PC program for x-ray Monte Carlo
PICU Paediatric Intensive Care Unit
RDS Respiratory Distress Syndrome
RIS Radiological Information System
RR Relative Risk
SIR Standardised Incidence Ratio
STM Sosiaali– ja terveysministeriö, Ministry of Social Affairs and
Health
STUK Säteilyturvakeskus, Radiation and Nuclear Safety Authority of
Finland
UNSCEAR The United Nations Scientific Committee on the Effects of Atomic
Radiation
“Life is a risky process – so risky that none of us will escape it alive” (Hendee
1991).
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1 Introduction
The balance between beneficial effects and unwanted damage is often hard to
find when ionising radiation is used purposely or when radiation protection
measures are going to be taken. Decisions about how to regulate radiation
exposure have to take into account the physical, medical, political, economic
and ethical aspects of radiation exposure as well as take into consideration
both the individual and collective dose of the population. (International
Commission on Radiological Protection 1991, Christensen 2000).
According to the Council of the European Commission (1997), the
Council Directive 97/43/Euratom on the health protection of individuals
against the dangers of ionising radiation in relation to medical exposure has to
be implemented in Member States of European Union. In Finland it was
implemented by decree 423/2000 of Finnish Ministry of Social Affairs and
Health concerning patients and by law 1142/1998 concerning radiological
personnel. According to the decree, “special protection requirements are
needed in childhood and during pregnancy”. These demand appropriate
radiological equipment, practical techniques and ancillary equipment for the
medical exposure of children. The quality assurance programmes, including
quality control measures and patient dose, need special attention (Council of
the European Commission 1997). In 2000, there were 4.1 million x-ray
examinations (0.79 examinations per inhabitant) in Finland, including 4114
pelvimetry x-ray examinations (Hakanen 2002) and 348 400 x-ray
examinations of children under 16 years of age in 1995 (Heikkilä et al. 1998).
According to Rytömaa (2003), about 1000 new cancer cases/year appear in
Finland due to ionising radiation and 120 of them are due to medical exposure
(Servomaa & Komppa 1998).
It is considered that patient protection can be improved by continuously
comparing local practice with the dose reference levels of doses to patients
(International Commission on Radiological Protection 73, 1996). Leitz (2003)
believes in a five percent dose reduction, which means 800 manSv/year in
Scandinavia. All measured doses should be saved together with the individual
exposure data (kV, mAs, grid use, image receptor system and the generator)
(Schneider 1998). This is important because the dose received by a patient
should be estimated afterwards (Sosiaali- ja terveysministeriö 2000) and
according to many studies, the effective dose varies widely – even in the same
examination and with similar imaging receptors (Kettunen 1996, European
Commission 1996, Rannikko et al. 1997a, Hieta & Rautio 2000, Kettunen &
13
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Servomaa 2003). A study of children undergoing chest radiography showed
that some children received 40 (Schneider et al. 1993), even 71-fold doses, the
lowest dose measured (Doll & Wakeford 1997). Chest (63.7%) and abdomen
(11.2%) x-ray examinations are the most common for children up to 1 year of
age (Jones et al. 2001, Siironen 2003). In a CT examination, it is possible to
reduce the dose to infants (children less than 1 year of age) between 35 to 70%
by optimising the scanning parameters suitable for infants (Chan et al. 1999,
Huda et al. 2001, International Atomic Energy Agency 2001). The weight of a
newborn (a child less than four weeks of age) may range from 0.360 kg to 6 kg
or more and exposure parameters should vary similarly (Chapple et al. 1992,
Lindskoug 1992, Martin et al. 1994, Wraith et al. 1995, McDonald et al. 1996,
Ruiz et al. 1996).
The United Nations Scientific Committee on the effects of Atomic
Radiation (UNSCEAR 1993) has emphasised that due to the highly mitotic
state of a child’s cells, radiation risk is strongly dependent on the child’s age at
the time of exposure. Radiation exposure in the first ten years of life is
estimated to produce a risk of the total aggregated and the radiation dose to the
foetus increases the risk of cancer by about 6% Sv-1 (International Commission
on Radiological Protection 84 2000, Paile 2002a). In addition to age, individual
differences between human beings are also important (Dowsett et al. 1998,
Cook et al. 2001, Mustonen et al. 2002). Individuals with certain diseases
(ataxia, teleangiectasia) have increased risk of carcinogenesis from ionising
radiation (Land 1995) but these deviant groups are small and are not
significant in general (Auvinen 2002). Newborns that are premature or ill from
birth may require a number of x-ray examinations during their early weeks
and this may bring about a marked radiation dose. The number of premature
infants increased in 1987–2000 from 4.9% to 5.6% of newborns (Marttila 2003).
From stochastic point of view, there is no evidence at present of a
threshold to the radiation dose below which there is no risk. This means that
any radiation dose, no matter how small, can have a potential harmful effect.
The probability – but not the severity – of stochastic harm increases along with
increased exposure. (Committee on the Biological Effects of Ionizing Radiation
1990, International Commission on Radiological Protection 60, 1991). The
detriment must include not only the estimates of fatal cancer but also other
deleterious effects of radiation. The International Commission on Radiological
Protection 60 (1991) considers the components of the detriment due to the
radiation exposure of the whole body to be at low doses. These include the risk
of fatal cancer in all relevant organs and a specific allowance for differences in
latencies, which results in different values of expected life lost to fatal cancer in
14
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different organs. They also include an allowance for morbidity resulting from
induced nonfatal cancers and for the risk of serious hereditary disease in all
future generations from irradiated individual. Detriment can best be thought
of as the probability of causing a level of total harm judged to be equivalent to
one death caused by a loss of about 15 years lifetime. (Committee on the
Biological Effects of Ionizing Radiation 1990, International Commission on
Radiological Protection 60, 1991, Marshall et al. 1994, International
Commission on Radiological Protection 73 1996, International Commission on
Radiological Protection 84, 2000). The natural spontaneous risks to an embryo
or foetus during pregnancy of bearing a handicapped child is about 3% (Brent
1980) and in the United Kingdom, the natural incidence of severe mental
retardation in adolescence is about 4–5 per 1000 (Mole 1979). The natural
cumulative risk of fatal childhood cancers at the age of 15 years is about
7.7·10-4 (National Radiological Protection Board 1993a).
All individual medical exposure should be justified in advance by taking
into account the specific objectives of the exposure and the characteristics of
the individual involved. The referring physician and the practitioner should
seek, where practicable, to obtain previous diagnostic information or medical
records relevant to the planned exposure and consider this data in order to
avoid unnecessary exposure. All doses due to medical exposure for radiological
purposes should be kept as low as reasonably achievable and consistent with
obtaining the required diagnostic information whilst taking into account
economic and social factors (ALARA). (International Commission on
Radiological Protection 60, 1991, Gron et al. 2000, Niittylä 2000, Niittylä &
Kahlos 2000). The clinical responsibility regarding individual medical exposure
attributed to a practitioner involves justification and optimisation. These
include clinical evaluation of the outcome, co-operation with other specialists
and staff, obtaining information, if appropriate, concerning previous
examinations, providing existing radiological information and/or records to
other practitioners and/or prescribers as required and giving information as
appropriate on the risk of ionising radiation to patients and other individuals
involved (Council of the European Commission 1997, Sosiaali- ja
terveysministeriö 2000). Before a diagnostic procedure is performed it should
be determined whether a patient is, or may be, pregnant and whether the
foetus is in the primary radiation beam. In Finland, there are about 400 000
pelvic and lower abdomen plain x-ray examinations, 36 000 barium enema and
urinal x-ray examinations and about 40 000 pelvic and lower abdomen CT
examinations per year (Hakanen 2002). In every case of known or possible
foetal exposure to ionising radiation, a foetal dose estimate has to be produced
15
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and the results of this estimate have to be conveyed to the woman’s physician.
The pregnant patient has the right to know the magnitude and type of expected
radiation risks to her baby as a result of foetus exposure. (Laki potilaan
asemasta ja oikeuksista 1992, Pettersson et al. 2003). A methodology for
performing dose calculations, a standard letter and information package to
present to physicians must be developed. It is recommended that the current
set of references, upon which both estimates and reports could be based, be put
into use in radiological departments. (Council of the European Commission
1997, European Commission 1998, Karam 2000).
The purpose of this study is to determine the way in which the demands
set by degree 423/2000 by the Ministry of Social Affairs and Health to protect
the most radiosensitive individuals are fulfilled by estimating the radiation
dose and radiation risk to the foetus from x-ray examinations of an expectant
mother, to find out the practices involved in preventing does to embryos and
foetuses and dose estimation practices in the cases when the embryo or foetus
are exposed and to estimate radiation dose and risk due to the radiation
exposure of one special group: newborns treated in a paediatric intensive care
unit. A further aim of this study is to develop a proposal that will act as a guide
for good practices during the pelvic or lower abdomen x-ray examination of a
woman of reproductive age.
16
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2 Review of the Literature
The review of the literature consists of the concepts radiation risk and
detriment, radiation doses to the foetus and newborns and the factors affecting
these doses. The keywords used in searching for articles from the databases
were radiation dose, radiation dose and pregnancy, radiation dose and foetus,
radiation dose and child, radiation risk, radiation dose and newborn, radiation
dose and infant, effects of ionising radiation. The databases used were Medline
and Medline Public, Cinahl and Journals Ovid Full Text and Inis (the database
of the International Atomic Energy Agency, IAEA).
2.1 Radiation Risk and Detriment
The question of the genetic and somatic risks of ionising radiation was known
at the beginning of 20th century (Auvinen 2002). It came widely to the forefront
of attention in the aftermath of World War II when nuclear weapons were
developed and employed over Hiroshima and Nagasaki. Since then, the field of
radiation genetic risk estimation and risk estimates themselves have evolved
and several important advances have been made. Up to about the mid-1980s,
this evolution was driven primarily by progress in mammalian radiation
mutagenesis studies, especially mouse studies, with much less impact from
that in human genetics. The situation began to change in the early 1990s with
the incorporation of emerging human genetics (human molecular genetics) into
the conceptual framework of risk estimation. (Sankaranarayanan 2000,
Auvinen 2002).
The effect of exposure is measured as a radiation risk, which expresses
the probability of an event, e.g. of dying from cancer. Risk can be expressed as
relative risk (RR), which is the probability of the disease due to radiation
exposure compared to the reference population without exposure (Auvinen
2002). For instance, if in ten years’ follow-up, the incidence of thyroid cancer is
10 per 100 000 person years in the group of exposed persons and 5.8 per 100 000
in the unexposed comparison group, the relative risk of thyroid cancer among
the exposed is 10/5.8 = 1.7 (a 70% higher risk among exposed). Another
possibility is to use absolute risk, which is the occurrence of the disease
expressed as a probability (Auvinen 2002). In this example, the absolute risk of
thyroid cancer among exposed persons is 1·10-5 per year. Applied to the
previous example, this gives an absolute excess risk of (10–5.8) 10-5/Sv =
4.2·10-5/Sv (Committee on the Biological Effects of Ionizing Radiation 1990,
17
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International Commission on Radiological Protection 60, 1991, Dowsett et al.
1998, Auvinen 2000, International Commission on Radiological Protection 64
2001). Chapple et al. (1994) found in their study that the maximum risk was
between 8.4·10-6/Sv and 3.9·10-5/ Sv. They point out that lifetime risks may be by
a factor of up to 2–4 times greater than this. Ringertz and Bremmer (2001)
have given an example of the relations: if age at exposure is less than 10 years,
the relative lifetime risk of detrimental effects is 1 and if the age is from 30 to
40 (over 50) years, the risk is between 0.25–0.35 (0.15–0.20).
The protection of the foetus and children needs particular consideration
because they are highly radiosensitive during the entire period of prenatal
development (International Commission on Radiological Protection 90, 2003).
The risk to the newborns or to the foetus may be 2–3, or even 4 times, as high as
that in the population of 30–40 years of age and 5–7 times greater than after
the age of 50 years. (International Commission on Radiological Protection 60,
1991, Brent 1992, Chapple et al. 1992, National Radiological Protection Board
1993a, International Commission on Radiological Protection 73, 1996, Cook et
al. 1998, Dowsett et al. 1998, Auvinen 2000, Karam 2000, International
Commission on Radiological Protection 84, 2000, Cook et al. 2001, Paile 2002a).
2.2 The Effects of Ionising Radiation on the Embryo, Foetus, and
Newborns
2.2.1 Biological Effects
The biological effects of radiation are caused by a damage in DNA which cannot
be repaired by the cell itself (Nias 1998a, Paile 2002b). The effects can be
grouped into deterministic and stochastic. Deterministic effects are clinically
observable only if the radiation dose is above a certain threshold. The severity
of the effect (massive cell killing) increases with the dose. (International
Commission on Radiological Protection 60, 1991, Le Heron 1992, Nias 1998b,
International Commission on Radiological Protection 84, 2000, International
Commission on Radiological Protection 2001, Mettler 2001). The cells in
children and foetuses undergo rapid division during the growth of the different
organs and they become specialised into function in the role that they
eventually get in the mature organism. Both cell division and differentiation
into mature functional cells are connected with radiation sensitivity. (Prasad
1995, Christensen 2000, Paile 2002b).
18
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Stochastic effects from radiation can result from mutational changes in
cells that retain their ability to divide (unprepared or misrepaired DNA
damage). These modified cells may sometimes initiate a malignant
transformation of a cell, leading to the development of a malignant clone and
eventually to a cancer. The period between the initiation and the manifestation
of the disease may extend from a few years (leukaemia, thyroid cancer) to
several decades (colon and liver cancer). In addition, genetic effects may be
initiated due to the irradiation of germ cells (hereditary effects). For stochastic
effects, no threshold dose is assumed and the probability of their occurrence is
believed to be proportional to the dose. Therefore, keeping the dose as low as
possible should reduce the probability of their induction. (International
Commission on Radiological Protection 60, 1991, National Radiological
Protection Board 1993a, European Commission 1998, International
Commission on Radiological Protection 84, 2000, International Commission on
Radiological Protection 2001). The recent results indicate that low doses may
be more harmful than believed earlier (Hall 2002, Paile 2002b, Hall et al. 2004).
Exposure to the pelvic region (pelvis and abdomen) of a pregnant woman may
cause the death of the foetus, malformation, growth retardation, mental
retardation and heritable effects. These deterministic effects have a quite high
threshold (generally above 1 Gy). The problem in radiation protection is the
possibility of stochastic effects; even only one hit can induce mutation, a DNA
strand(s) break and years later a cancer – if the cell cannot repair the damage.
(Travis 1997, International Commission on Radiological Protection 89, 2002,
International Commission on Radiological Protection 90, 2003).
The classic triad of radiological embryological syndromes is lethal effects,
congenital malformations and growth disturbance (Travis 1997). The function
of many organs and tissues is not affected by small reductions in the number of
available healthy cells (International Commission on Radiological Protection
60, 1991, UNSCEAR 1993, Sharp et al. 1998, Nakashima et al. 2002). This is
why it has been presumed that none of these potential hazards presents a
significant problem at the low exposures (0.01–0.1 Gy) used in conventional
diagnostic procedures (Sharp et al. 1998).
The effects of radiation exposure on an embryo depend on the time
exposure occurs in relation to conception. The development of the unborn child
can be divided approximately onto three major phases: the pre-implantation
(from conception to implantation; 1–9 days after fertilisation), major
organogenesis (4–9 weeks of pregnancy) and the foetal development or foetal
stage (from the 9th week of pregnancy until birth). (Travis 1997, Timins 2001,
Jacquet 2002, International Commission on Radiological Protection 90, 2003).
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2.2.2 Lethal Effects on the Embryo
The most radiosensitive period (for the criterion of lethality) is the first three
weeks after conception (Prasad 1995). The most likely result of excessive
radiation during this pre-implantation stage is spontaneous abortion
(miscarriage), which may go unnoticed because of the high background rate (up
to 35%) (International Commission on Radiological Protection 60, 1991, Ornoy
et al. 1996, Dowsett et al. 1998, European Commission 1998, Sharp et al. 1998,
Karam 2000, Paile 2002a). This is the reason why radiation exposure of the
embryo in the first 3 weeks following the conception is not likely to result in
any detriment to a live-born child (International Commission on Radiological
Protection 60, 1991, International Commission on Radiological Protection 73,
1996). The death of an embryo is usually caused by cytogenic damage during
the implantation period. Post-implantation death reaches its maximum 16
days after conception. (International Commission on Radiological Protection
90, 2003).
2.2.3 Malformation of the Foetus
The major formation of the central nervous system takes place during the 8th to
15th weeks of pregnancy, when it is most radiosensitive; from weeks 16 to 25 it
has lesser sensitivity (International Commission on Radiological Protection 60,
1991, International Commission on Radiological Protection 2001, Timins 2001,
International Commission on Radiological Protection 90, 2003) and after week
25, the foetal central nervous system is relatively radio resistant (Schull &
Otake 1999). During the period of main organogenesis, there may be some
malformations in the organs under development at the time of exposure.
(International Commission on Radiological Protection 84, 2000, Timins 2001,
Paile 2002a). Studies have shown that it is possible to produce some
malformation mutation during the first days of pregnancy (International
Commission on Radiological Protection 90, 2003), but it is rare.
Lower than expected intelligence quotient (IQ) values have been
reported in some children exposed in uterus in Hiroshima and Nagasaki; about
30 IQ points per Sievert relate to the dose to the unborn child from the 8th to
15th weeks (International Commission on Radiological Protection 73, 1996,
Otake et al. 1996, Otake & Schull 1998). There was also a dose-related increase
in the frequency of children classified as “severely retarded”. Severe mental
retardation was observed following exposure in the 8th to 15th week after
conception (dose over 0.5 Gy) but the possibility it may be caused by
significantly lower doses could not be excluded (Servomaa & Paile 1999). Paile
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(2002a) gives her opinion that the “finger tips” of radiation-produced mentally
handicap are microcephaly and mental retardation. There is no complete
understanding of the mechanism by which prenatal irradiation interferes with
the complex and precisely programmed development of the mammalian brain
and nervous system. (Committee on the Biological Effects of Ionizing Radiation
1990, UNSCEAR 1993, International Commission on Radiological Protection
73, 1996). According to Ornoy et al. (1996), there were no differences in the
results of medical and neurological examination or in the motor or cognitive
areas between embryonic or foetal children irradiated by low doses (under
5 rad = 50 mGy). According to Damilakis and Tzedakis (2002) and Damilakis et
al. (2003a), a conceptus dose investigation is necessary if there is the possibility
of a foetal dose higher than 10 mGy.
There is evidence of the effect of a radiation dose on the reduction in the
height of atomic bomb survivors (Willman et al. 1994, Nakashima et al. 2002)
and among long-term survivors of childhood cancer patients (Sklar et al. 1993,
Cicognani et al. 1994, Otake et al. 1994).
The latest study by Hall et al. (2004) indicates that a radiation dose to the
brain may produce disturbance in intellectual development at radiation doses
equivalent to those of computed tomography. The effective radiation dose in a
head CT to infant is 7.6 +/- 3.1 mSv (Huda et al. 2001). Leitz and Jönsson (2001)
have reported an average dose of 68 mGy to the brain of adults in Sweden and
the dose to infants is assumed to be about 30% higher. According to Brenner et
al. (2001), estimated doses to an infant in a head CT are about 100 mGy.
2.2.4 Carcinogenic Effects on the Foetus and Newborn
2.2.4.1  Early Findings in Radiation Detriments
Stewart et al. (1956, 1958) initially reported evidence that diagnostic
radiography might be carcinogenic for the foetus. They suggested that
radiographic examination during pregnancy had approximately doubled the
risk of a child developing cancer. MacMahon (1962) reported very similar
findings in the northeastern United States based on contemporary hospital
records of exposure. The prevalence rate of abdominal x-ray examinations
during pregnancy recorded by Stewart et al. (1956, 1958) was very similar to
that recorded in corresponding periods during national surveys in 1957, 1958
and 1970.
The Oxford Survey of Childhood Cancers (OSCC) covers all children in
Great Britain less than 16 years of age dying from malignant disease
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(5276 case-control pairs in 1981). Nearly three-quarters of the information
concerning pregnant women exposed during pregnancy, worldwide, has been
obtained by the OSCC. Bithell and Stewart (1975) and Wakeford and Little
(2003) analysed the OSCC data and they expressed their uncertainty about the
effects of radiation. In these studies, the relative risk is about 1.4 (Bithell 1989,
Bithell 1993). The OSCC data showed that the relative risk was highest for
cancer deaths occurring between the ages of 4 and 7 years (Knox et al. 1987).
Harvey et al. (1985) conducted a case-control study in Connecticut on
over 32 000 twins. Their conclusion was that low-dose prenatal irradiation
might increase the risk of childhood cancer. Sorahan et al. (1995) reported an
80% increased risk of cancer in children who received prenatal x-ray exposure.
MacMahon (1985) supposed, “It seems likely that the question of the
association between foetal irradiation and childhood cancer will fade into
medical history unresolved and remain the source of more confusion than
enlightenment”. According to Wakeford and Little (2003), the OSCC data and
the Japanese (atomic bomb) cohort irradiated in-utero support the causal
explanation found in case-control studies and implies that doses to foetus in-
utero of 10 mSv increase the risk of childhood cancer.
Shea et al. (1997) found that there might be association between
preconception paternal x-ray exposure and a baby’s birth weight and Meinert
et al. (1999) suppose that there may be some connection between paternal
preconception exposure and leukaemia, but the result is very uncertain.
In reported studies (Table I), the risk in an exposed group varies but most
of them have shown a slightly increased risk of leukaemia following x-ray
exposure in-utero. According to Auvinen (2000), the mechanism for greater
susceptibility among children remains unclear. In addition, there has been
divergence in the radiation protection community regarding the magnitude
and generality of the effect of prenatal radiation on the risk of childhood cancer
(International Commission on Radiological Protection 90, 2003).
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Table I. Prenatal exposure to diagnostic x-rays and risk of childhood cancer.
Reference Type of Study  Primary site Number of 
Subjects 
Case/control 
Risk in exposed 
group 
Bithell and 
Stewart (1975) 
Case-control All cancers 8.513+8.513 Leukaemia: OR=1.5 
Solid tumour:  
OR =1.5 
Kaplan (1958) Case-control Leukaemia 150+150 OR=1.4 
Ford et al. (1959) Case-control All cancers 244+306 Leukaemia: OR=1.6 
Other ca: OR=1.8 
Polhemus and 
Koch (1959) 
 Case-control Leukaemia 317+317 OR=1.3 
Murray et al. 
(1959) 
Case-control Leukaemia 65+65 OR=0.9 
Court Brown et 
al. (1959) 
Cohort Leukaemia 40,000 SIR=0.9 
Gibson et al. 
(1960) 
Case-control Leukaemia 319+884 OR=1.6 
MacMahon(1962) Case-control All Cancers 556+7.242 All cancers: OR=1.4 
Leukaemia: OR=1.3 
Guntz and  
Atkinson (1964) 
Case-control Leukaemia 102+102 OR=1.1 
Ager (1966) Case-control Leukaemia 129+217 OR=1.1 
Graham et al. 
(1966) 
Case-control Leukaemia 319+884 OR=1.5 
Diamond et al. 
(1973) 
Cohort Leukaemia 20,000 +35,000 RR=1.6 
Monson and 
MacMahon 
(1984) 
Case-control All cancers 1.342+14.294 Leukaemia OR=1.4 
(age 0–19) 
OR=1.52 (age 0–9) 
Harvey et al. 
(1985) 
Case-control 
within cohort 
All cancers  32+128 Leukaemia: OR=1.6 
All cancers: OR=2.4 
Rodvall et al. 
(1990) 
Case-control 
within cohort 
All Cancers 95+190 Leukaemia: OR=1.7 
CNS: OR=1.5 
Stjernfeldt et al. 
(1992) 
Case-control Leukaemia 216+301 Leukaemia: OR=1.8 
Solid tumour:OR=0.9 
Naumburg et al. 
(2001) 
Case-control Leukaemia 624+624 OR=1.14 
Shu et al. (2002) Case-control Leukaemia 1.842+1.842 OR=1.2*) 
OR=1.0**) 
OR=2.4***) 
(According to Auvinen 2000, ICRP 90 2003) 
*) all in-utero exposed  
**) leukaemia diagnosed < 6 years 
***) leukaemia diagnosed at 11–14 years of age 
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2.2.4.2  Latest Conclusions
The latest conclusions attempt to emphasise the practical consequences and
potential implications of the updated but still limited knowledge on genetic
susceptibility to radiation-induced cancer (Piechowski 2000, Salomaa 2002,
International Commission on radiological Protection 90, 2003) and effects in
the early stages of gestation (Hall 2002, Jacquet 2002, International
Commission on radiological Protection 90, 2003, Hall et al. 2004). A developing
embryo and foetus is radiosensitive throughout the prenatal period in-utero.
Low radiation doses (less than 0.1 Gy) can cause pre-implantation death
caused mainly by cryogenic damage (International Commission on
Radiological Protection 90, 2003).
The most vulnerable period for radiation-induced cancer appears to be
the first years of life (Naumburg et al. 2001). The age dependence of a
radiation-induced risk is observed for the cancers most readily induced by
radiation: leukaemia, thyroid cancer and breast cancer (Auvinen 2000). The
spontaneous risk of childhood leukaemia and cancer is (2–3)·10-3 per Gy and a
prenatal radiation exposure of 10 mGy has been reported to increase the risk
by 0.06% to 40% (International Commission on Radiological Protection 84,
2000, Timins 2001, Pettersson et al. 2003, Wakeford & Little 2003). For thyroid
cancer, a very high susceptibility has been observed up to the age of 4 years. For
breast cancer, susceptibility decreases in almost linear fashion until
approximately 50 years of age. (Committee on the Biological Effects of Ionizing
Radiation 1990, UNSCEAR 1993, Auvinen 2000).
Doll and Wakeford (1997) highlight that the carcinogenic affects of the
irradiation of a foetus and child should not be expected to be same. The cells
that give rise to most of the typical childhood cancers (other than leukaemia)
persist and are capable of dividing for only a short time, if at all, after birth.
Bithell and Stiller (1988) modelled the risks by trimester, taking into account
the number of x-ray films. The excess relative risk/mGy in the first trimester
was 0.28 and in the third trimester, it was 0.03. There is evidence that the low
dose irradiation of a foetus in uterus (particularly in the last trimester) causes
an increased risk of childhood cancer (Brent 1992, Dowsett et al. 1998, Karam
2000, Timins 2001) and the evidence does not suggest that the risk is not zero at
doses of the order of 10 mSv (Wakeford & Little 2002). The increased risk is
produced by doses in the order of 10 mGy; in these circumstances, the excess
risk is approximately 6% per Gy (1:1700). Without irradiation, one child of five
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hundred children will get childhood cancer. If the foetus’s dose is 10 mGy, it
means a 30% higher risk of childhood cancer. A radiation dose of 35 mGy during
pregnancy gives a double risk of childhood cancer (Servomaa & Paile 1999);
according to Sharp et al. (1998), the risk is double by dose of 25 mGy to the age
of 15 years. For United Kingdom national rates, the baseline risk of cancer in
the first 15 years of life is 1 in 650 and about half of these cancers are fatal (the
excess lifetime fatal cancer risk is 0.5%) (Sharp et al. 1998). Because of the
cancer risk, x-ray examinations with high doses of the pelvis (CT, fluoroscopic
imaging dose with several tens of mGy) should especially be avoided during
(presumed) pregnancy (International Commission on Radiological Protection
84, 2000, Damilakis et al. 2001, Timins 2001, Kusama & Ota 2002). Cardiac
catheter ablations (Damilakis et al. 2001) or surgical treatment of hip fractures
can be performed, if necessary, during all trimesters (Damilakis et al. 2003b)
because in typical procedure, the dose to a foetus is less than 1 mSv. Table II
summarizes the effects of the irradiation of a human embryo during different
periods in the development of the foetus.
Radiation doses for paediatric x-ray examinations should be kept to a
minimum because of the higher risks of radiation exposure to children
(Al-Balool & Newman 1998). From the radiation protection point of view, the
most important organs are specified by the International Commission on
Radiological Protection 60 (1991). In addition, the latest studies have indicated
that there may also be some effects on the lower levels (Paile 2002c, Wikman
2002, International Commission on Radiological Protection 90, 2003,
Pettersson et al. 2003) and consequently the optimisation of an individual dose
is important. Wakeford and Little (2002) point out that the evidence suggests
the risk is not zero at doses in the order of 10 mSv. The dose for the foetus is
higher in the second and third trimester (Damilakis et al. 2003a) and smaller
during the first trimester, with empty bladder (due to the depth of the uterus)
(Perisinakis et al. 1999, Damilakis et al. 2001).
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In addition, the latest studies have indicated that there may also be some
effects on the lower levels (Paile 2002c, Wikman 2002, International
Commission on Radiological Protection 90 2003, Pettersson et al. 2003) and
consequently the optimisation of an individual dose is important. Wakeford and
Little (2002) point out that the evidence suggests the risk is not zero at doses in
the order of 10 mSv. The dose for the foetus is higher in the second and third
trimester (Damilakis et al. 2003a) and smaller during the first trimester, with
empty bladder (due to the depth of the uterus) (Perisinakis et al. 1999,
Damilakis et al. 2001).
2.3 Radiation Doses to the Embryo and Foetus Due to a
Mother’s X-ray Examinations
Exposure of the pelvis and abdomen should be avoided during pregnancy
whenever possible. The examination of pelvic region of a pregnant woman is
justified under exceptional circumstances whenever the benefit from the
clinical data generated is likely to outweigh the potential risk to the expectant
Table II. Effects of irradiation on the human embryo.
Days after 
fertilisation 
Period of  
development 
Effects  
1 to 9 
(1–21) 
pre-implantation Most probable effects: 
death with little chance 
of malformation 
10 to 12 implantation Reduced lethal effects; 
malformation unlikely; 
intra-uterine growth 
retardation predominant 
effect 
13 to 50 
(22–64) 
organo-genesis Production of congenital 
malformation; retarded 
growth 
51 to 280 
(65–280) 
foetal Effects of CNS; growth 
retardation at high 
doses 
All foetal/neonate Increased incidence of 
cancer and leukaemia 
(4th week -) 
(Adapted from the International Commission on Radiological Protection 60, 1991, 
Dowsett et al. 1998, International Commission on Radiological Protection 90, 2003) 
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mother or foetus. The management of radiation risk during pregnancy needs
good communication and lateral thinking by experienced practitioners.
(Council of the European Commission 1997, Parry et al. 1999, International
Commission on Radiological Protection 84, 2000). The major practical problem
is the detection of early, unsuspected pregnancy prior to radiation exposure
(Malone 1997, Sharp et al. 1998, Chahed et al. 2000) or accidental injuries when
the expectant mother may be e.g. unconscious. The patient may not be aware of
her pregnancy or medical personnel fails to obtain this information (Pettersson
et al. 2003). Afterwards, this may cause great anxiety to the pregnant woman
(Meller 2003) and legal responsibility to staff. Osei and Faulkner (1999a)
reported the results of 50 pregnant women undergoing radiological
examination of the lower abdomen or pelvis, when the embryo/foetus was near
or included in the x-ray beam. Most of these women were unaware of their
pregnancy at the time of their radiological examination. When they afterwards
discovered that they were pregnant, they sought advice from their physicians
on the foetal dose and risk. The Radiation Protection Advisor estimated the
foetal dose based on their knowledge of the technique factors and examination
details using normalised uterine doses published by the National Radiological
Protection Board. The gestational ages ranged from 2–24 weeks. The data
indicated that there was no risk of serious radiation-induced somatic (e.g.
cancer induction) or deterministic effects. There opinion is that the in-utero
exposure to diagnostic x-rays present a very low total risk to a developing
embryo or foetus when compared with the other effects (approximately 30–50%
of human embryos abort spontaneously in pregnancies) (Brent 1980, Jones &
Russel 1987).
Chahed et al. (2000) analysed 17 cases of pregnant women who were not
aware of the pregnancy. The gonad doses were up to 52 mGy. There were four
minor abnormalities, but they could not be attributed to the effects of
irradiation because of the low dose. However, they suggest that the termination
of pregnancy should be justified if the dose to the embryo is over 50 mGy.
Generally it is concluded that only very rarely, if at all, will the level of foetal
irradiation in diagnostic radiography justify the termination of a pregnancy
(Chahed et al. 2000, Fenig et al. 2001). Only in women who have undergone
several x-ray examinations in which the foetus is in the primary x-ray beam or
when both radiographic and fluoroscopic examinations have been performed, it
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is necessary to calculate or measure the level of radiation. Abortion should be
considered when the dose level is above 50–100 mGy (Ornoy et al. 1996, Fenig
et al. 2001). Berlin (1996) reported two cases. The first was 28-year-old woman
who underwent a series of lower gastrointestinal and chest radiographs. The
dose was 10 mGy (the foetus was 4 weeks in gestational age). The other case
was a 30-year-old woman who was given 25.75 MBq of iodine-131, a dose
3.4 mGy (the foetus was 5 weeks in gestational age). The 30-year-old patient
went into a labour prematurely and she gave birth to an infant with multiple
congenital anomalies (the foetus died two months later). The 28-year-old-
woman had a full-term pregnancy; this child had several birth defects,
including microcephaly and congenital heart disease (cf. Paile 2002a).
Damilakis et al. (2000) reported the foetal dose during a CT examination
of the abdomen varied from 33 to 46 mGy in the second trimester and 28 to
42 mGy in the third semester. In Iran, there were over 1340 Iranian pregnant
patients exposed to diagnostic x-rays from 1984–1994. The age of the pregnant
patients varied from 15 to 51 years. The average foetal dose was
6.8 +3.81 mGy with over 10 to 90 mGy (more than 37%) (Ardabi 2001). In
Sweden, Pettersson et al. (2003) conducted a 12-month survey in three
hospitals where they examined 28 000 woman aged 15–50 years and 21 cases of
exposure to pregnant patients were reported. In the second phase, the RIS
(radiological information system) data and national population records of
woman aged 15–50 years were connected. They found 299 cases of foetal
exposure out of 19 000 x-ray examinations carried out in three hospitals, which
indicates that 1.5% of the female patients were pregnant during the x-ray
examination. The reported foetal doses are summarised in Table III.
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2.3.1 Preventing a Radiation Dose to an Embryo and Foetus
Women of reproductive age presenting for an examination in which the
primary beam irradiates directly, or by scatter, the pelvic region (essentially
any ionising irradiation between the diaphragm and the knees) or for a
procedure involving radioactive isotopes should be asked whether they are or
may be pregnant. The prescriber and the practitioner should ask whether she
is pregnant. If pregnancy cannot be excluded, special attention should be given
to the justification, particularly the urgency, and to the optimisation of the
medical exposure, taking into account the exposure both of the expectant
mother and the unborn child. This is especially important if abdominal and
pelvic regions are going to be exposed (International Commission on
Radiological Protection 60, 1991, Council of the European Commission 1997,
Dowsett et al. 1998, Schneider 1998, Sharp et al. 1998, International
Commission on Radiological Protection 84, 2000, Sosiaali- ja terveysministeriö
2000, International Commission on Radiological Protection 2001, Faulkner
2002). If the patient cannot exclude the possibility of pregnancy, she should be
asked if her period is overdue. The problem is that understanding the practice
of and the radiation protection guidelines for females is inconsistent and there
is significant unfamiliarity with the protection rules internationally and
nationally, even within a hospital (Abd El-Bagi et al. 2001, Faulkner 2002)
because of the lack of an international consensus.
If there is no possibility of pregnancy, the examination can proceed. If the
patient is definitely, or probably, pregnant (i.e. menstrual period overdue) the
justification for the proposed examination should be reviewed by the
radiologist and the referring physician. They have to make a decision on
whether to defer the investigation until after delivery or until the next
menstrual period has occurred. However, a procedure of clinical benefit to the
mother may also be of indirect benefit to her unborn child and a delay in an
essential procedure until later in pregnancy may increase the risk to the foetus
as well as to the mother. If pregnancy cannot be excluded, but the menstrual
period is NOT overdue and the procedure gives a relatively low dose to the
uterus, the examination may proceed. If the examination gives relatively high
doses (e.g. abdominal and pelvic CT, IVUs or fluoroscopy), there should be
discussion taking into consideration locally agreed recommendations. In all
cases, if the radiologist and the referring physician agree that the irradiation of
the pregnant or possibly pregnant uterus is clinically justified, this decision
should be recorded. The radiologist must then ensure that the exposure is
limited to the minimum required to acquire the necessary information. If it
becomes obvious that a foetus has been inadvertently exposed, despite the
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above measures, the small risk to the foetus due to the exposure is unlikely to
justify, even at higher doses, the greater risks of invasive foetal diagnostic
procedures (e.g. amniocentesis) or those of a termination of the pregnancy.
When such inadvertent exposure has occurred, an individual risk assessment
based on the knowledge of the technique factors, simulating the examination
using a phantom loaded with dosimeters or reviewing scientific literature,
should be made by a radiation physicist and there should be discussion with the
patient concerning the results. (European Commission 1998, Sharp et al. 1998
Goldman & Wagner 1999, Timins 2001, Faulkner 2002).
2.3.2 Practice of X-ray Examination if the Patient is Pregnant
The International Commission on Radiological Protection (1977) put forward
in publication 26 a proposal for a so-called 10 day rule, which was later reversed
in publication 60 (1991) because of new knowledge. Statute 423 (2000) and
MED directive (1997) strongly stress the importance of avoiding the
unnecessary irradiation of a pregnant woman. Before an x-ray examination,
the presence of pregnancy should be evaluated if the woman is of reproductive
age. This means that a woman between the ages of 12 and 50 years should be
asked explicitly orally or in writing whether she might be pregnant or may
have missed a period (International Commission on Radiological Protection 84,
2000, International Commission on Radiological Protection 89, 2002). The
outcome of such questioning should be recorded (Timins 2001). Menstrual
history may or may not be reliable in determining pregnancy. For example, a
young girl who comes to hospital with her parents may deny a pregnancy that
she suspects (International Commission on Radiological Protection 84, 2000).
The use of contraceptives such as the contraceptive pill or coil does not
necessarily guarantee non-pregnancy. (Council of the European Commission
1997, European Commission 1998). Surveys of attitudes in individual centres
indicate wide variations in practices e.g. in Europe. Some centres use the 10-
day rule (x-ray examinations of the pelvic region should be performed during
the 10-days following the onset of a period). In other centres, the 28 days rule is
used (if the patient is not sure if she is or is not pregnant, the date of the last
period is checked and if it started more than 28 days previously, consideration
would be given to postponing the examination) (Hart 1994, Malone 1997, Sharp
et al. 1998, Faulkner et al. 2001). Some would regard pregnancy as unlikely
unless the patient reported a missed menstrual period. Others routinely
undertake pregnancy tests, despite the questionable reliability of such tests in
very early gestation. It would appear that considerable misunderstanding
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exists even among radiation specialists. Bury et al. (1995) put forward a
proposal to revive “the 10 days rule” if the dose to the uterus is high (>10 mSv).
Malone (1997) and the National Radiation Protection Board (1993a) propose
the use of  “ten-day rule” in situations where the foetal dose will contribute up
to “several tens of mGy”. In such cases the examination should be done with 10
days of the start of a period (Bury et al. 1995). In low dose examinations, the
examination can be performed if the uterus is out of the beam or if the patient
is not pregnant (Council of the European Commission 1997). The referring
physician when writing the referral has to find out whether the embryo or
foetus will be in the direct beam and whether the procedure is a relatively high-
dose examination (International Commission on Radiological Protection 84,
2000). The professional who performs the examination has final responsibility
for the irradiation of the foetus. According to the law on patients’ rights (Laki
potilaan oikeuksista 1992), a patient has right to decide herself whether the
examination is to be performed, after she has received information about the
risk to the foetus, the advantages of the x-ray examination and the possibilities
of other modalities.
The exclusion of pregnancy would be less critical for a patient
undergoing diagnostic radiography of the wrist or head than for the patient
having a CT of the abdomen (Meller 2003); an examinations between knees and
diaphragm needs attention (Bury 1995). The European Commission (1998)
issued a schematic overview that gives a guide on how to check whether a
patient is pregnant (Appendix A).
2.3.3 Guidelines for Preventing a Dose to an Embryo or Foetus Due to X-ray
Examinations
In order to minimise the frequency of unintentional radiation exposure to an
embryo and foetus, there should be an informative poster in hospital waiting
rooms with the text: “Patients, staff and relatives: Please inform the staff if you
think that you might be pregnant” (Appendix B) (European Commission 1998).
A picture of a pregnant woman in the poster captures the attention of people
who cannot read or are from other countries. ICRP 84 (2000) proposes the same
idea:
“IF IT IS POSSIBLE THAT YOU MIGHT BE PREGNANT, NOTIFY THE
PHYSICIAN OR RADIOGRAPHER/TECHNICIAN BEFORE YOUR X-RAY
EXAMINATION.”
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These types of advisory notices should be posted at several places in
radiological departments to increase the awareness of women of reproductive
age coming for an x-ray examination. This information is particularly
important in reception area and other areas where diagnostic x-ray equipment
is used (Berlin 1996, European Commission 1998, Sharp et al. 1998,
International Commission on Radiological Protection 84 2000, Arranz et al.
2001, European Community 2001, Faulkner et al. 2001, Timins 2001).
In some cases, women arrive unconscious and receive a predetermined
“trauma series” of x-rays immediately upon arrival. A CT examination may
follow these if internal injuries seem likely. In such cases, the patient’s health
depends on accurate information about potential injuries and, if the woman’s
life were at risk, knowledge of pregnancy would not lessen the need for such
procedures. (Goldman & Wagner 1999, Karam 2000). According to Mann et al.
(2000), approximately 30% of all trauma victims are female in their
childbearing years (10–50 years old). Of these trauma victims, 15% are
definitely or possibly pregnant at the time of injury. Especially in those cases
but also for protecting the medical staff in the event of a poor outcome of the
pregnancy, it is important to record the technique used in the x-ray
examination for latter requirements (Goldman & Wagner 1996, Karam 2000,
Mann et al. 2000).
According to Finnish laws in force (Council of the European Commission
1997, Sosiaali- ja terveysministeriö 2000), the x-ray technique should be
recorded in order to later assess a patient’s dose from an x-ray examination. To
estimate the dose, the documentation of technical factors (whether a grid was
used, peak voltage, dose rate, fluoroscopy time, films and projections used) is
particularly important for a patient of childbearing age (Goldman & Wagner
1999, International Commission on Radiological Protection 84, 2000, Timins
2001, International Commission on Radiological Protection 89, 2002).
2.3.4 Basic Principles When Planning the X-ray Examination of a Pregnant
Patient
When pregnancy is confirmed but exposure to ionising radiation is
unavoidable, the referring physician and the physician directing the exposure
and the patient should discuss three questions. The discussions should cover
topics including justification for the procedure and maintaining maternal
health, with emphasis on the relevance of maternal wellbeing for the
continuation of the pregnancy. Discussions should include consideration of the
urgency of the exposure: only procedures deemed critical to maternal health
36
STUK-A204
would be acceptable. The risk-benefit considerations for the radiology of a
pregnant woman are complicated because the risks to both mother and child
must be considered. These should include an assessment of the risk to the
mother if the examination is postponed with regard to benefits; the mother
receives a direct benefit, whereas the foetus usually benefits indirectly (Osei &
Faulkner 1999a, Faulkner et al. 2001).
Optimisation of the exposure to ensure that doses are kept as low as
reasonably achievable (ALARA), consistent with obtaining the required
diagnostic information (International Commission on Radiological Protection
60, 1991, UNSCEAR 1993, International Commission on Radiological
Protection 89, 2002). If the prescriber and the practitioner justify the
examination, taking into account pregnancy, it is the ultimate responsibility of
the mother to decide if the examination should be performed after being
informed of the possible consequences to the unborn child (European
Commission  1998, Laki potilaan asemasta ja oikeuksista 1992). The dose to the
unborn child should be estimated before the examination is carried out and, if
relevant, reassessed afterwards (Council of the European Commission 1997,
European Commission 1998). There may be situations when a series of
conventional radiographs of the lower abdomen could be precipitated. In these
situations, the cumulative dose should be estimated (Faulkner et al. 2001).
As a psychosocial issue, the situation prescribed above is very
complicated because the natural instinct of the mother is to avoid a risk of the
foetus. In many situations, it appears to be a natural reaction to minimise risks
of serious damage. Thus, with elective procedures, many could not accept a low
probability risk where the damage may be significant, as they see no need to
take the risk. In such circumstances, it is arguably improper for a profession to
remove the right of the individual not to take the risk through not providing
them with the knowledge that they are exposed to it. This is a matter of great
sensitivity; individuals should be entitled to make a fully informed decision
about how they will determine their own course of action. This area is very
problematic. (International Commission on Radiological Protection 60, 1991,
Bury et al. 1995, Malone 1997). With trauma patients, when a mother’s life is in
a danger, the possibilities of deleterious radiation effects never outweigh foetal
or maternal survival (Goldman & Wagner 1999).
2.3.5 Factors Effecting on the Dose of the Foetus
The actual foetal dose depends on radiographic equipment used, the size of the
patient, the location (or position) and the size of the foetus and the methods
used to perform the examination and whether the foetus is in the primary x-ray
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beam (Rannikko et al. 1997b, Mann et al. 2000).
The foetal dose also depends on the depth of the foetus in the maternal
body, since tissues lying between the surface of the patient and the pregnant
uterus attenuate the x-ray beam entering the body. The position and size of the
foetus change during the course of pregnancy. (Osei & Faulkner 1999b,
Damilakis et al. 2000) and is significantly related to mother’s BMI as seen in
Figure 1. During the first trimester, the embryo depth ranges from 4 to 10 cm
depending on the individual (Perisinakis et al. 1999). The main reasons are the
status of the bladder and the maternal BMI.
Figure 1. The embryo skull (A) and abdomen depth (B) related to mother’s BMI (body
mass index (Adopted from Perisinakis et al. 1999).
During the first trimester, the embryo dose is approximately the same as the
uterus dose (Osei & Faulkner 1999a) but in the second and third trimester, it is
not equal to the uterus dose (Damilakis et al. 2003a). Table IV shows some
examples of the radiation doses to the foetus in different trimesters in
computed tomography (CT) and in one angiographic procedure.
In Barium Enema radiation, the dose varies from 19 mGy to 81 mGy and
it is under 50 mGy if the fluoroscopy time is less than 7 minutes (Damilakis et
al. 1996). Appendix E summarises examples of radiation doses to the foetus in a
single helical CT and in a multislice (four-slice) CT.
The amount of exposure is an important factor in increasing the
radiation dose to the foetus. Table V shows approximate foetal doses per single
radiograph in the abdomen or pelvis, with the foetus in the primary field,
compared with mother’s thickness.
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Table IV. Approximate foetal radiation doses from diagnostic procedures at different
gestational ages.
Table V. Estimated foetal dose for a single radiographic view of the abdomen or
pelvis with the foetus in the primary field.
Patient thickness 
cm 
Estimated dose (mGy) 
 Ap view Lateral view 
14–15 1 0.7 
16–19 1.5 1 
20–23 2.1 1.5 
24–26 3.1 2 
27–30 4.3 3 
31–34 5.6 4 
Adopted El-Khoury and Madsen (2003) 
 
Table VI summaries the main technical factors affecting the radiation dose to
a foetus in different modalities using x-rays.
Examination First 
trimester 
 
mGy 
Second 
trimester 
 
mGy 
Third 
trimester  
 
mGy 
Chest Helical CT 
Winer-Muram et al. 
(2002) 
0.0033–0.0202 0.0079–0.0767 0.0513–0.1308 
Abdomen CT*) 
Damilakis et al. 
(2000) 
 30.0–43.6  29.1–42  
Cardiac catheter 
ablation*) Damilakis 
et al. (2001) 
0.1018–0.2043 0.3 0.557 
*) Depth of the conceptus 5.5 cm, 8.5 cm and 11.5 cm 
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Table VI. Factors affecting foetal radiation dose from radiological procedures.
Exposure mode/factor Explanation Comments 
 All x-ray modalities  
Beam filtration Aluminium filtration is 
used to harden beam by 
absorption of low-energy 
photons that will not pene-
trate tissue to produce 
image 
Increasing filtration will 
reduce dose 
Tube current (mA) The current generated by 
the tube during the radiol-
ogy series 
Lower mAs produces lower 
dose  
Tube voltage kVp The tube voltage on the 
electrons that generate the 
x-ray beam 
Increasing kVp   gives more 
energetic photons and 
lower dose 
 Conventional x-ray  
Number of films and There may be multiple 
films of some locations 
Some of the shots will have 
marginal impact on radia-
tion dose to conceptus (foe-
tus in direct beam or not) 
Fewer films means lower 
dose 
Shots of extremities and 
head produce virtually 
exposure to the conceptus 
 Fluoroscopy  
Fuoroscopy Most fluoroscopy units will 
retain the last image hold 
Shorter fluoroscopy time 
results in smaller dose 
Distance to patient The patient-tube distance 
will vary depending on the 
size of the patient and the 
geometry of the setup 
Greater distance reduces 
the dose 
 CT  
Slice thickness The thickness of the slice of 
tissue imaged during each 
pass of the CT 
Dose is largely independent 
slice thickness, assuming 
beam collimation is 
properly set 
Pitch The distance between  
adjacent slices, which 
might not be contiguous 
Greater pitch reduces dose 
Dose increases with narrow 
slices 
Number of slices and loca-
tion of uterus 
The total number of slices  
Slices exposed the concep-
tus in the primary field. In 
addition, there will proba-
bly be more slices (and 
more secondary radiation) 
either above or below the 
conceptus in beam area 
A lower number of slices 
results in lower exposure 
because of reduced dose 
from scattered radiation) 
(In accordance with Karam 2000) 
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Foetal size and depth are important when estimating foetal dose during the
second and third period of pregnancy (Osei & Faulkner 1999a, Damilakis et al.
2000, Damilakis & Tzedakis 2002) but as seen in Table VII, so are the used tube
peak voltage and filtration influence to the foetus dose. It is possible to reduce
the dose to the foetus in an x-ray examination of the pelvic region about 70% by
optimising the imaging technique, film-focus distance, the peak voltage,
cassette’s material and film-screen combination (Grondin et al. 2004).
Table VII. Normalized conceptus dose data in mGy/mGy for an AP abdominal
examination performed on a pregnant woman during the second and third trimesters
(12-pulse generator, FSD 100 cm, field size 34x32 cm, phantom thickness 26.4 cm on
second and 29.4 cm o the third semester).
 Total filtration (mmAl) 
kVp Trimester 2.5 3.0 3.5 4.0 4.5 
80 Second 0.439 0.455 0.474 0.487 0.504 
 Third 0.359 0.372 0.389 0.403 0.413 
90 Second 0.490 0.506 0.526 0.543 0.567 
 Third 0.402 0.415 0.431 0.445 0.456 
100 Second 0.531 0.546 0.565 0.578 0.592 
 Third 0.436 0.451 0.465 0.476 0.489 
(In accordance with Damilakis et al. 2002). 
 
The relative dose to the foetus by PCXMC decreases strongly when the foetus is
outside the primary beam (Figure 2). When the foetus is more than 10–12 cm
from the exposed area, the dose to the foetus is theoretical. (Servomaa &
Kettunen 2004).
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Figure 2. Effect of the foetus distance from the edge of the primary beam to the
relative dose of the foetus (FSD 100 cm, 80 kV, 3 mmAl, 20x20 cm2).
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A posterior-anterior projection will give a lower dose to the embryo than
anterior-posterior project (Appendix C) (Osei & Faulkner 1999a, Osei &
Faulkner 1999b, Damilakis & Tzedakis 2002) because the mother’s body
absorbs radiation. In computed tomography (Parry et al. 1999), according to
Wagner et al. (1997), the dose to the middle of the patient is 70% of the surface
dose with a variation +30%. The inaccuracy depends on beam energy, patient
size and scanning volume. If a surface dose of 30 mGy is in the pelvic region, the
conceptus dose is between 12 mGy and 30 mGy.
2.3.6 Special Radiological Examinations During Pregnancy
For many years, x-ray pelvimetry was the standard for providing anatomic
dimensions and a quantitative assessment of the maternal pelvis; the use of
ultrasound examination has significantly reduced the number of x-ray
pelvimetries (Claussen et al. 1985, Thomas et al. 1998). In Finland, there were
5,083 pelvimetry x-ray examinations in 1996 (Rannikko et al. 1997a) and 4,121
in 2000 (Hakanen 2002). Usually, an x-ray pelvimetry examination is taken
during the 36th to 40th weeks of pregnancy (Standertskjöld-Nordenstam et al.
1988). In conventional x-ray examinations with a grid, this comes to 3
exposures of the patient; two small field area exposures in the anterior position
and one large area field in the lateral view (Borell & Fernström 1960, Axelsson
& Ohlsen 1979). The dose absorbed by a foetus from conventional pelvimetry
has decreased to 0.46–1 mGy (Russell et al. 1980, Ferguson et al. 1996,
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Lecomber et al. 1998), from 5–20 mGy per film (Auvinen 2000) in the early
1940s, and can vary up to 40-fold (Thomas et al. 1998). The lowest foetal doses
are measured for pelvimetry with a radiography air-gap or rare earth screens
(0.1 mGy) and digital plates or fluoroscopy and a digital spot image (0.07–
0.12 mGy) (Axelsson & Ohlsen 1979, Badr et al. 1997, Holje et al. 1997,
Lecomber et al. 1998). In modified digital CT pelvimetry, the doses have been
0.1–0.44 mGy by the low-dose settings specified and with a lateral topogram
and an axial CT slice (Pritchard & Hufton 1981, Federle et al. 1982, Suramo et
al. 1984, Adam et al. 1985, Claussen et al. 1985, Moore & Shearer 1989,
Ferguson et al. 1996, Badr et al. 1997, Lecomber et al. 1998). The World Health
Organization (1999) proposed not to carry out pelvimetry on a routine basis
and it should be undertaken only on rare occasions but according to
Balleyguier et al. (2003), the multidetector CT is replacing conventional CT
pelvimetry because of a shorter acquisition time and easily understood final
images.
Ultrasonic examinations provide most of the information required by
obstetricians and do not utilise ionising radiation (International Commission
on Radiological Protection 84, 2000). During last decade, magnetic resonance
imaging of the foetus (FMRI; Foetal Magnetic Resonance Imaging) has gained
considerable interest. FMRI is a non-invasive modality and provides better soft
tissue contrast and the possibility of tissue characterisation both with 0.5 T and
with 1.5 T MRI systems. (Hata et al. 1990, Revel et al. 1993, Garel et al. 1998,
Michel et al. 2002).
2.4 The X-ray Examinations of Newborns in an Intensive Care
Unit
Diagnostic radiology plays an important role in the diagnosis and treatment of
newborns (including premature infants born under 37 weeks of gestational
age) requiring intensive care. The alveolar epithelial cells secrete surfactant,
which decreases the surface tension at the interface between the air and
alveolar surface, maintaining patience of the alveoli and preventing collapse of
the lung, at 23 to 24 weeks (Godderidge 1995). Radiographs are most commonly
taken in the neonatal period to assist in the diagnosis and management of
respiratory difficulties. Respiratory distress syndrome (RDS), also called
hyaline membrane disease due to the lack of surfactant (Clements & Avery
1998), pneumonia, pneumothorax, collapsed segment of lung, position of the
umbilical arterial catheter or an endotracheal tube, are the main indications
for taking a chest x-ray (Fletcher et al. 1986, Arroe 1991, Donoghue 2000).
Intestinal infections (necrotic enterocolitis) are indications of an abdominal
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x-ray of a newborn (Swingler et al. 1998, Lowe et al. 1999, Jones et al. 2001).
The overall incidence of RDS is approximately 1% of all infants (Zimmerman
1995) and in these cases, characteristic chest x–ray findings show a ground-
glass haze in the lung surrounding air-filled bronchi (air bronchogram),
characterized by diffuse reticulogranular infiltrates, atelectasis and air
bronchograms, often progressing to severe bilateral opacity. (Walther &
Taeusch 1992, Marttila 2003). In Finland, the overall incidence of RDS among
premature infants with very low birth weight (under 1000 g) and surviving for
more than 12 hours was 760 per thousand (Tommiska et al. 2001).
The most premature infants are still at the greatest risk for severe RDS
and frequently develop complications (e.g. infection, patent ductus arteriosus
and central nervous system haemorrhage) which all contribute to prolonged
requirements for oxygen and ventilator support (Marttila 2003). According to
Greenough et al. (2000), the majority of very immature infants have an
abnormal chest radiograph appearance. However the number of bedside chest
radiographic examinations performed each year increases because the
intensive care of the premature infants have improved during last decades
strongly (Wilson-Costello et al. 1996).
Two projections of chest and abdomen are produced during the prenatal
period: either as a single exposure usually taken at the first exposure time
(anterior posterior supine chest and abdomen and lateral chest and abdomen)
or as two separate exposures from chest and abdomen ap and lateral (Heikkilä
et al. 2001, Jones et al. 2001). There is no significant difference in effective
doses between these two techniques (Jones et al. 2001) if it is necessary to
evaluate both the chest and abdomen region. The criteria for a good image are
peak inspiration, no rotation or tilting, the cervical trachea to T12 /L1 must be
included and pulmonary vessels and trachea and major bronchi must
reproduce. In addition, the diaphragm and costo-phrenic angles must be
visually sharp and the paraspinal lines, retrocardiac lung and mediastinum
should be clearly reproduced. The recommended technical values for exposure
for an 800 g, 29-week-old newborn are 62 kV, 0.8 mAs, 2.5 mmAl and a 400-
speed screen-film combination and no grid. The accurate collimation of the
x-ray beam (chest; to diaphragm, chest and abdomen; also pelvis), lead rubber
shield on the incubator or on the baby immediate proximity to the beam are
also required. (Godderidge 1995, European Commission 1996, Cook et al. 1998).
Later, only the chest ap is taken as a matter of routine and the chest and
abdomen ap or lateral view is taken only when the paediatrician separately
asks for the projection. Other examinations are quite rare during the neonatal
period (Wilson-Costello et al. 1996, Heikkilä et al. 2001, Siironen 2003).
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Although many diagnostic studies in paediatric intensive care units
(PICU) are made routinely for the purposes of monitoring and surveillance, the
value and incremental gain of repeated chest radiographs are frequently not
considered (Pollack et al. 1987). The value of routine chest radiographs in
critically ill patients has been evaluated (Hauser et al. 1989, Sivit et al. 1989,
Hall et al. 1991, Spitzer et al. 1993, Marik & Janower 1997, Swingler et al. 1998,
Greenough et al. 2001) with varying recommendations for the frequency of
chest radiographs. Performing routine daily chest radiography is justified by
the assumption that a significant percentage of routine chest radiographs
shows a clinical pathologic process requiring medical intervention (Greenbaum
& Marschall 1982). Others believe the use of routine portable chest
radiographs to be unwarranted (Sanada et al. 1991, Brainsky et al. 1997). Some
suggest that decreased variability in ordering practice and fewer chest
radiographs per patient results cost savings to the patients and payers (Hauser
et al. 1989, Price et al. 1999). The value of daily chest radiographs is not
supported simply by whether they show new findings but that these findings
change treatment (Marik & Janower 1997, Helfaer 1999, Greenough et al.
2000, 2001). Hakulinen (1992) reported on the premature infants at the age of
two years and born in the Kuopio area from 1978–1982, 3% had chronic BPD
(Broncho-Pulmonal Dysplasy). According to Marttila (2003), the incidence of
RDS has changed towards lower gestational age due to the decreased incidence
rate among preterm infants born after 30 weeks.
2.4.1 Specific Features of the Premature Infant as a Client in Radiological
X-ray Examination
The overall number of births per year in Finland decreased from 60 223 in 1987
to 57 371 in 2000 but the rate of preterm births increased from 5.6% to 6.3%
(Marttila 2003) including about 3000 premature infants born in Finland every
year. About 300 of them are under 1000 g in weight (extremely low birth
weight, ELBW) (Korhonen 1996). The smallest premature infants require the
special treatment given in the PICU in university hospitals. The smaller the
premature infant is the more exacting care is needed and the more x-ray
examinations are taken (in small sampling 10–41, on average 21 times/baby
(Korhonen & Perttunen 2002); premature infants weighing less than 750 g on
average 31 x-ray examinations/infant (Wilson-Costello et al. 1996). In addition,
a small premature infant has no (or very low) resistance to infections and other
disturbances. The skin of a premature infant is very thin and there is very little
fat under the skin. The head of a premature infant is big, the area of the body in
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relation to the weight of the body is large and the system is immature. That is
why a premature infant needs all its energy to grow and to maintain body
temperature. If the cassettes put in an incubator are cold or the doors of the
incubator are open for too long, the baby loses temperature. Because the body
tries to keep the optimal temperature stable, it uses all possible energy to
produce heat and it may be exposed to metabolic disturbances. The need for
extra oxygen increases, which is why all energy needed for recovery is spent on
heating. (Godderidge 1995, Korhonen 1996). It has been estimated that a 3.5 kg
foetus consumes about 53.3 kcal/kg/d to enable a weight gain of 120 g. This
estimate is based on an oxygen usage of 5 ml/kg/min. If an oxygen usage of
8 ml/kg/min is assumed, the energy requirement is 74.6 kcal/kg/d; the weight
gain requires about 17.5 kcal/kg/d. The daily energy requirement for a foetus is
100–140 kcal/kg/d. (Korhonen 1996).
Depending on her or his age, a premature infant often needs respiratory
treatment or support for ventilation to get sufficient oxygen (Greenough et al.
1999). The intubator tube has to remain without moving when the baby is
raised to get the image receptor under its back. In addition, other possible
wires have to be taken in consideration. (Godderidge 1995). Pain rates the
heartbeat and blood pressure and lowers oxygenation. Changes in blood
circulation act as an intermediary and may even lead to cerebral haemorrhage.
Assessment of the pain felt by premature infant is difficult and needs a lot of
experience. Despite this, one of the babies’ basic rights is get treatment for her
or his pain. The aim of nursing is that the vital functions of the infant remain
stable and that the infant has no pain and is protected against infection.
All these facts have to be taken into consideration when giving
premature infant an x-ray examination. The radiographer has to plan the x-ray
examination carefully in advance and then work very quickly, gently and
effectively to disturb the baby as little as possible. (Godderidge 1995, Korhonen
1996) Newborns are non co-operative and the frequency of breathing is fast,
causing the possibility for higher retakes. (Wall et al. 1986, Chapple et al. 1992,
Wraith et al. 1995). The exposure parameters based on the patient’s age are not
ideal in all cases, especially with premature infants. According to Lindskoug
(1992), in chest examinations, the weight of the patient should frequently
determine the exposure parameters. Because of the small size of neonates, a
positional shift of just 1–2 cm can bring about a magnitude change in organ
doses (Chapple et al. 1994). In chest x-ray examinations, the range of exposure
is usually 1–2 (Wall et al. 1986, Almen et al. 1996) but the number of projections
and exposures of one patient have not widely been reported (Almen et al. 1996,
Wilson-Costello et al. 1996, Mooney & Thomas 1998).
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2.4.2 Factors Affecting the Radiation Dose of a Newborn and a Premature
Infant
The radiation doses from x-ray examinations carried out in neonatal units
must be at a minimum while the quality of the radiographic image is optimised.
Wide variations have been found in the techniques, equipment performance
and radiation dose in different hospitals both in European and Finnish
hospitals (Wraith et al. 1995, Servomaa et al. 2000a). The results indicate that
substantial dose reductions could be achieved without loss of image quality
both in conventional and digital systems (Schneider et al. 1993, Wraith et al.
1995, Jonsson et al. 1996, Kyriou et al. 1996, McParland et al. 1996, Cook et al.
1998, Bond 1999, Cook et al. 2001). In children’s chest examinations, the given
EU directives with a sensitivity class of 400–600 seem to be impracticable for
the imaging plates (Gindl 2002). Beam energy, filtration and collimation, the
use of grid, the anode heel-effect, patient size, the screen-film combination and
film processing conditions affect the patient dose in conventional radiography
and most of them in computed radiography. In addition, the wide latitude in
digital radiography (both imaging plates and large-area detector based on
Caesium Iodide/Amorphophous-Silicon or Amorphous Selenium, flat panels)
needs attention to avoid the use of excessively high kilovoltages and tube
currents in order to reduce possible noise and get better DQE (detective
quantum efficiency) and MTF (Modulation Transfer Function). (International
Commission on Radiological Protection 34, 1982, Curry et al. 1990, Bushong
1993, Carlton & Adler 1996, Schaefer-Prokop & Prokop 1997, Lowe et al. 1999,
Parry et al. 1999) The benefit of digital systems is picture processing, which is
very useful with the visibility of pneumothorax and different catheter (Goo et
al. 2001).
There are many ways to reduce the dose to children. The selection of high
speed screen-film systems (at least speed class 400), which are typical for
different examinations and take into consideration the requirement for high
resolution, should always be weighted (Almen et al. 1996, European
Commission 1996, McParland et al. 1996, Cook et al. 1998, Parry et al. 1999).
According to Huda et al. (1996), the computed radiography of the chest requires
approximately twice the exposure of a 600-speed screen-film system. In other
research, the computed radiography reached by a 25% lower dose with the
same image quality as a film-screen system at a speed class 400 (Seifert et al.
1998) and in another with imaging plates necessitates about 75% more
exposure (Dobbins et al. 1992, Launders & Cowen 1995). The conclusions have
conflicted; the use of digital systems such as imaging plates or flat panels needs
more critical evaluation and a new attitude for radiographers and radiologists.
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According to Strotzer et al. (2000), because the latitude in digital systems is
wide, it is very difficult to overexpose them, which could result in patients
being exposed to unnecessarily high doses of radiation. The staff have to know
how to choose the optimal dose level to avoid the use of excessively high dose
levels “just to make sure” (Jönsson & Leitz 2002). These systems need a lot of
attention to get the image quality and dose to the optimal level but the quality
of the images must still be good enough (i.e. spatial resolution) for diagnostics
(Durand et al. 1995, Maccia et al. 1996, Spahn et al. 2000). According to Samei
et al. (2003) and Strotzer et al. (2002), the flat panels give a good resolution and
no significant difference in diagnostic quality even with a decreased radiation
dose. Völk et al. (2000, 2004), Strotzer et al. (2000) and Hamers et al. (2001)
have shown in their studies that it is possible to get a 50% or even 75% decrease
in the dose without significant differences in image quality and Ludvig et al.
(2002) have shown a 50% decrease in radiation dose compared with the film-
screen system speed class 400. A portable flat panel system offers rapid
availability in the PICU (e.g. Samei 2003).
The photostimulable phosphors generally have lower x-ray absorption
efficiency, which is why they have higher noise levels than screen-film systems
for the same radiation exposure. (Huda et al. 1996) Imaging plates and other
computed radiography systems (ccd; charge coupled device: flat panel, FPD)
are more sensitive to low energy scattered radiation than conventional screen-
film combinations because of the lower K-edge absorption energy of imaging
plate phosphor (Tucker et al. 1993, Sandborg et al. 1994, Wandtke 1994, Huda
et al. 1997, Parry et al. 1999). Seifert (1998) found that added filtration and the
use digital radiography could produce dose reduction of 50% in the chest ap
radiographs of neonates. Cohen et al. (1989) proved that it is possible to reduce
mAs by 25–33% with digital images and still get similar quality images as with
the conventional for the same patients. The number of retakes is lower because
over or under exposure is rare (Tarver et al. 1990, Lindhardt 1996, Oda et al.
1996, Seibert et al. 1996). Medical imaging management with PACS systems
allows better monitoring of radiology practice (UNSCEAR 2000) and makes it
possible to have “a second opinion” from a specialised paediatric radiologist via
teleradiology systems (Parisi et al. 1998, International Atomic Energy Agency
2001, Pohjonen et al. 2002, ).
Image quality is considered to be of primary importance in children’s
x-ray examinations (Kyriou et al. 1996, Cook et al. 1998). It is strongly advised
that the use of an antiscatter grid is unnecessary with infants because infants
are small, despite the higher sensitivity to scattered radiation when using
imaging plates or flat panels. If there is need for a grid, the same reduction of
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scattered radiation is achieved with an air-gap (Office for Official Publications
of the European Communities 1996, Cook et al. 1998). The patient dose could be
reduced substantially by increasing the filtration of an x-ray beam, either with
additional filters of aluminium whilst largely maintaining adequate image
quality (Wang et al. 1984, Dowsett et al. 1998) or with other materials
(Villagran et al. 1978, Chakera et al. 1982, Burgess 1985, Nelson & Jennings
1986, Wesenberg et al. 1987, Massaoumzahed et al. 1998, Doyle & Brennan
1999).
Shrimpton et al. (1988) point out in particular that the small reductions
in patient dose from the use of increased beam filtration would be weighted
against the cost of such filters, their possible detrimental effect upon image
contrast and the concomitant need for additional tube loading. Adequate
additional tube filtration of 0.1 mmCu–0.2 mmCu or the equivalent is
recommended for equipment having an existing total filtration of about
2.5 mmAl for almost all examination in order to absorb the soft part of the
radiation spectrum which unnecessarily contributes to patient dose without
significantly affecting image quality (Wraith et al. 1995, European Commission
1996).
With respect to imaging plates, Pärtan (2001) has recommended using
rather lower kV than with film-screen combinations because of the decrease of
the DQE with over 80 kV (with beam filtration of 2–3 mmAl), although Kump
and Shi (1999) found in their experiments that the 117 kV and the large area
flat panel (a-Si) had a 2–3 times greater integrated DQE and 2–3 times greater
dynamic range compared with a screen-film images. However, high kV
techniques, which allow a reduction in mAs and exposure time, produce a
significant reduction in dose as well as movement blurring (Chapple et al. 1992,
Office for Official Publications of the European Communities 1996, Council of
the European Commission 1997, Cook et al. 1998, Rehani 2001, Duggan et al.
2003). That means that the smallest patients need the most powerful machines:
12-pulse or high frequency multi-pulse generators are required because the
waveform also affects the dose. For a 10 month old infant, a chest x-ray with
identical blackening requires an exposure more than 20-times longer and
allows a 2.15 times higher Entrance Surface Dose when a 1-pulse generator is
used instead of a converter generator (Office for Official Publications of the
European Communities 1996).
Dose saving can also be performed by using low attenuation materials
(carbon) in table tops (Sutton & Cranley 1996, Hufton & Russell 1986, Rehani
2001) and cassettes (Hufton & Russell 1986, National Radiological Protection
Board 1990, Dance et al. 1997, Brennan & Hourihan 1998). The anode heel
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effect makes dose reduction possible with a large exposure area and a short
film to focus distances because there is less radiation on the anode side and so
the right positioning of the output beam reduces dose on the thinner part
(Carlton & Adler 1996, Fung & Gilboy 2000).
Lead and rubber shielding of the parts of the body next to the primary
beam should always be used in children’s x-ray examinations to protect them
against primary and scattered radiation. Radiosensitive cell-forming bone
marrow is present in most bones at birth. The developing breast, thyroid and
gonads are also sensitive to radiation detriment and they must be protected.
(Fletcher et al. 1986, Committee on the Biological Effects of Ionizing Radiation
1990, International Commission on Radiological Protection 60, 1991, National
Radiological Protection Board 1993b, UNSCEAR 1993, International
Commission on Radiological Protection 73, 1996, Office for Official Publications
of the European Communities 1996, Cook et al. 1998) In neonatal radiography,
a contact vinyl rubber on the infant’s body can achieve the best protection.
Personal shields should always be used in an incubator because of better
hygiene and less loss of the baby’s body temperature (Faulkner et al. 1986,
Chapple et al. 1994, Wraith et al. 1995, Office for Official Publications of the
European Communities 1996, Cook et al. 1998). If that is not possible, a
hanging lead can be placed from the collimator to cast a shadow on the primary
x-ray beam or a shield lead masking techniques on the top of the incubator lid
can be used. (Barcham et al. 1997, Seeram 1997, Statkiewicz-Sherer et al. 1998)
The use of a lead shield does not increase the handling time of the baby (Russell
& Davies 1986). The radiographer always has to carefully collimate in spite of
the use of a lead shield and only the area of interest should be exposed.
(National Radiological Protection Board 1990, Radiation and Nuclear Safety
Authority 1994, Wilson-Costello et al. 1996, Cook et al. 1998, Palmer et al. 1998,
Schneider 1998, Cook et al. 2001, Rehani 2001).
There are many factors to be optimised to obtain an acceptable
diagnostic image with the lowest radiation dose (Lindskoug 1992, Bushong
1993, Vano et al. 1995, McParland et al. 1996, Cook et al. 1998) when handling
a small newborn with special needs and requirements. A training programme,
regular provision of dose information and collaboration between physicist,
radiographers and radiologists can significantly reduce the doses received by
infants (Martin et al. 1993, Brennan 1995, Almen et al. 1996, Roebuck 1999).
Educated and trained staff should take x-ray examinations of children
(Schneider et al. 1993, Rannikko et al. 1997a, Schneider 1998, Roebuck 1999,
Hogg et al. 1999, Cook et al. 2001). The use of a care sheet for each patient,
where the exposure factors for previous examinations are recorded, can assist
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with the careful choice of exposure factors more individually and even with
premature infants (Simpson et al. 1998, European Commission 2000, Duggan
et al. 2003)
2.5 Dose Reference Levels in Paediatric X-ray Examinations
Diagnostic dose reference levels are the dose levels given nationally in medical
radiological diagnostic practices for typical examinations for groups of
standard-sized patients (e.g. for adults 55–85 kg; mean 70 kg) (Havukainen
2001) or standard phantoms for broadly defined types of equipment. The dose
reference level corresponds to the 3rd quartile, 75% of individuals receive a dose
less than this value, i.e. these levels are expected not to be exceeded for
standard procedures when good and normal practice regarding diagnostic and
technical performance is applied (Office for Official Publications of the
European Communities 1996, Council of the European Commission 1997). If
the doses are too high, in the upper part of dose range, patients may get
unnecessarily high doses and if doses are in the lower part, the image quality
may be poor (Papadimitriou et al. 2001). It is therefore important to assess
image quality in relation to patient dose and be able to get a striking and
significant dose reduction. The criteria for good radiographic technique must
be also met. (Schneider et al. 1992, 1993.) The European guidelines on the
quality criteria for diagnostic radiographic images in paediatrics (European
Commission 1996) give an 80 µGy Entrance Surface Dose as the reference level
in the chest ap of a newborn. The variation of Entrance Surface Doses in three
CEC paediatric trials for a newborn’s 1 kg in weight in a chest ap was from
11 µGy to 386 µGy; the mean was 45 µGy. ICRP Committee 3 (2001) has
proposed a dose reference levels including the ap chest of newborns (80 µGy)
and the NRPB (Hart et al. 2000) has proposed 50 µGy but due to insufficient
data, no national dose reference levels have been set in Finland for a child’s
bedside or a newborn’s chest examinations. The knowledge of dose levels in
comparison with other centres clearly indicated that there is a plenty of work to
do to get a reduction in radiation doses (Warren-Forward et al. 1996).
2.6 Estimation of the Radiation Risk in Childhood Due to
Radiation Exposure in the Uterus and After Birth
Risk estimates should be based on the estimated dose and stage of gestation
(Osei & Faulkner 2000). Every x-ray examination with the dose of some tens of
mGy’s to the foetus involves a considerable risk of childhood cancer. The foetal
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doses should be calculated in every radiological department. On the other
hand, Osei and Faulkner (2000) say: “If there are indications for a pregnant
woman to undergo a radiological examination, then the radiation risks seem to
be small problem compared with the advantages of the examination for the
mother or child”. Bithell (1993) has used the Adrian Committee (1958) data
with the time-dependent relative risk model to obtain a relative risk coefficient
of 0.051 per mGy (95% confidence interval 0.028–0.076). The absolute risk
coefficient of 8% per Gy (95% confidence interval 4.4–12.0%) may be derived
from the model. (Bithell 1993). Gilman et al. (1988) reached four conclusions
based on estimates by the Mantel-Haenszel techniques. Both the timing and
dose of a prenatal x-ray examination influence the risk of cancer and the
detailed consequences of these factors can be distinguished. They assume that
the timing of prenatal exposure is more important than the dose. They also
found that the nature of the maternal illness, which occasioned the prenatal
x-rays, was not important. They suggest that for first trimester x-rays the
cancer risk could be almost three times greater (earlier two times) (Knox et al.
1987) than the risk for other prenatal x-rays and six times as great as the risk
for non-x-rayed children (Gilman  et al. 1988). Furthermore, Rodvall et al.
(1990, 1992) suggested that a developing foetus may be more sensitive to the
carcinogenic effects of ionising radiation than children irradiated post-natal.
The National Radiological Protection Board (1993a) has adopted an
excess absolute risk coefficient of 6% per Gy for cancer incidence under 15
years of age following low dose irradiation in uterus. Forty percent of the risk
was estimated to be due to leukaemia (2.5% per Gy). It is slightly greater than
the risk of 1.8% per Gy estimated by the NRBP for a 10 mGy dose received just
after birth (Muirhead & Kneale 1989, National Radiological Protection Board
1993b, Osei & Faulkner 2000). The findings in studies by both Bienefeld and
McLaughlin (1998) mentioned that the risk of childhood cancer following
parental irradiation – preconception or during pregnancy – was equal.
Although a number of studies of children exposed to ionising radiation in-utero
have found evidence of increased cancer incidence (Knox et al. 1987, Gilman  et
al. 1988, Rodvall et al. 1990, Rodvall et al. 1992, Bithell 1993, Osei & Faulkner
2000), there are several others where these effects were not observed
(Bienefeld & McLaughlin 1998, Osei & Faulkner 2000). The single biggest
obstacle to studying this outcome is its rarity: most studies do not have the
power to address this question (Bienefeld & McLaughlin 1998, Rytömaa 2003).
The association between parental pre-conceptual exposure to radiation and
childhood leukaemia is unlikely (Tutty & Brennan 1999). Table VIII shows the
hereditary disease and cancer risk in some x-ray examinations (foetus in the
primary x-ray beam).
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Table VIII. Risk of hereditary disease and cancer following typical foetal diagnostic
medical exposure to ionising radiation.
The uterine dose provides an approximation of the mean dose to the foetus in
the first two months of gestation. In later stages of pregnancy, foetal size and
depth become more crucial in estimating foetal dose (Damilakis et al. 2000). In
literature, some simple rules are shown for the crude first approximation of
absorbed dose to the conceptus in three broad categories: low (<10 mGy),
intermediate (10–250 mGy) and high (>250 mGy). The doses are estimated at 2,
5 and 10 mGy respectively: 2 mGy per exposure (radiographs), 5 mGy per slice
(computed tomography) and 10 mGy per minute of fluoroscopy, when the
conceptus is within the x-ray field. (Mann et al. 2000.)
2.7 Methods of Estimating Radiation Doses Due To X-ray
Examinations to a Patient
Patient doses in diagnostic radiology can be measured in different ways. The
Dose-Area Product (DAP) is the absorbed dose in the air averaged over the area
of the radiation beam multiplied by the area of the beam in the plane where
dose is measured. It is normally given in Gycm2 or mGycm2. The dose-area is
the same wherever in the beam it is measured as long as the chamber receives
no scatter from the patient. Before use, the DAP meter must be calibrated. (Le
Heron 1992, Toivonen et al. 2001).
The Entrance Surface Dose (ESD) can be defined as the absorbed dose to
air at the point where the x-ray beam enters the surface of the patient stressed
by the backscatter factor (1.29 to 1.46). The backscatter factor depends on the
quality of the radiation beam (energy filtration of the x-ray beam and field size)
(Harrison 1983, Tapiovaara 1985, Grosswendt 1990, Cranley et al. 1991,
 Probability of disease per mean exposure 
Examination/procedure Mean foetal 
dose (mGy) 
Hereditary 
disease 
Fatal cancer to 
age 15 years 
Conventional x-ray    
Abdomen 1.4 1 in 30,000 1 in 24,000 
Barium enema 6.8 1 in 6,000 1 in 5,000 
Barium meal 1.1 1 in 38,000 1 in 30,000 
Iv-urography 1.7 1 in 24,000 1 in 20,000 
Lumbar spine 1.7 1 in 24,000 1 in 20,000 
Pelvis 1.1 1 in 38,000 1 in 30,000 
Computed tomography    
Abdomen 8.0 1 in 5,000 1 in 4,000 
Lumbar spine 2.4 1 in 24,000 1 in 14,000 
Pelvis 25 1 in 1 700 1 in 1 300 
(Sharp et al. 1998) 
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European Commission 1996, Harju et al. 2003). The unit for Entrance Surface
Dose is mGy. The entrance Surface Dose can be computed by the formula
ESD = BSF·(hc/hp)
2 ·Q·Y (2.7-1)
where Q is the output of x-ray beam/mAs at distance hc, BSF is backscatter
factor, hp is the distance from the focus to patient skin and the Y is the mAs
used in examination (Parry et al. 1999, Toivonen et al. 2001). The formula gives
a reliable result if data collection is made carefully (Toivonen et al. 2001, Kepler
et al. 2003). It is possible to calculate the Entrance Surface Dose from the Dose-
Area Product by dividing the Dose-Area Product by the exposed area on the
skin of patient and multiplying it with the backscatter factor (BSF) (Chu et al.
1998, Kepler et al. 2003).
ESDDAP = DAPread· hc*BSF/A· hp (2.7-2)
In formula A, the field size is measured on the film front from the patient
examination. DAPread is corrected by the calibration coefficient, which depends
on the tube potential. The ESD dose can also be measured directly with a
thermoluminescent dosimeter (TLD) (Servomaa et al. 2000a, Vartiainen 2000,
Toivonen et al. 2001).
The Entrance Surface Dose (ESD) or Dose-Area Product is suitable and
comparable for quickly assessing the practice in different x-ray departments
between different x-ray examinations or techniques but they are not very
satisfactory as total risk indicators. They are less useful when comparisons of
potential radiation detriment are required between different x-ray
examinations or techniques. (Le Heron 1992) Energy imparted to patients may
be used to study the relationship between the image quality and patient dose
(Almen & Nilsson 1996, Gkanatsios & Huda, 1997, Huda & Gkanatsios 1997)
but it is complicated to use in every day routine. The effective dose describes
the risk or harm caused by radiation to an individual (Council of the European
Commission 1997). It is not practical in a routine radiological procedure
(Lampinen 2000) but it is useful when making a comparison between different
techniques or modalities or assessing the risk of ionising radiation to an
individual (Servomaa 2000).
The effective dose was developed by ICRP to reflect the fact that some
organs are more sensitive than other organs. They have a higher risk of
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producing a cancer or another deleterious effect. The effective dose also helps
in evaluating the biological effects of radiation (Committee on the Biological
Effects of Ionizing Radiation 1990, UNSCEAR 1993, Nias 1998b, UNSCEAR
2000, International Commission on Radiological Protection 89 2002). The
effective dose is the sum of the effective doses for exposed organs. The
calculation of these doses requires knowledge of the size and configuration of
the individual, the geometrical projection of the beam, size and location of the
primary and scatter beams, Entrance Surface Dose and x-ray beam energy
spectrum. The radiation quality factor is needed because of the different
biological effects when interacting with tissue. For x-rays, the quality factor is
unity (Lampinen 2000), which according to International Commission on
Radiological Protection 74 (1996) and Marttila (2002) means that the effective
dose can be defined for x-rays as the sum of the weighted average absorbed
doses in all the tissues and organs of the body. The unit is Sv (Sievert).
International Commission on Radiological Protection 60 (1991) has produced a
list of tissue weighting factors for a number of organs and tissues and they are
mean values for the whole population. The calculation of effective dose is based
on the Monte Carlo technique described in NRPB-R186 (Jones & Wall 1985) or
direct organ dose measurements by TLD (McCollough & Schueler 2000).
Nowadays there are several computer-based programs for calculating
the effective dose, e.g. PCXMC and ODS-60 (Tapiovaara et al. 1997), and
estimating the dose and risk to the exposed foetus (Rannikko et al. 1997a,
1997b, Servomaa & Tapiovaara 1998, Hansen et al. 2003, Helmrot et al. 2003,
Osei et al. 2003).
PCXMC is a widespread and well tested Monte Carlo program for
calculating a patient’s organ doses and the effective dose in medical x-ray
examinations (e.g. Hart 1997, Carlsson et al. 1999, Lampinen 2000, Mooney et
al. 2000, Schmidt et al. 2000, Tapiovaara et al. 2000, Geijer et al. 2001, Kepler
2001, Papadimitriou et al. 2001, Tort et al. 2001, Dimov & Vassileva 2002,
Spoelstra et al. 2002, Hansen et al. 2003). The anatomical data is based on the
mathematical hermaphrodite phantom models of Cristy (1980), which describe
patients of six different ages: newborn, 1, 5, 10, 15-year-old and adult patients.
The height and weight of the patient can be set from a real patient. All organ
doses calculated by PCXMC relate to the patient entrance air kerma (free-in
air, without backscatter) at the point where the central axis of the x-ray beam
enters the patient. The datum can be obtained by combining data on the
examination techniques and the radiation output of the x-ray source or by
using the surface dose or Dose-Area Product measurements of actual patient
examinations. (Tapiovaara et al. 1997, 1999) This enables the calculation of the
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effective dose related to the x-ray field size and provides a technique for
monitoring the collimation of the x-ray field, which is important in paediatric
radiology because of the closer proximity of the sensitive organ (Gallini et al.
1992).
Still, there are many reasons making it difficult to estimate a foetal dose
(Servomaa & Paile 1999). Perisinakis (1999) and Osei and Faulkner (1999b)
found that the amount of urine in the urinary bladder influences the depth of
the foetus from 4 cm to 10 cm during the first trimester, depending on the
individual, the status of the bladder, and the maternal BMI. Figure 3 shows the
effect of the foetus depth on the foetus dose as calculated by FetDose program
(Osei et al. 2003).
Figure 3. The effect of the depth of the foetus to the Normalised Uterus Dose (NUD)
as calculated by FetDose program (Osei et al. 2003) during the first tremester
(Servomaa & Kettunen 2004).
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According to Tapiovaara et al. (1997), a change from 10 cm to 4 cm increases the
dose of the foetus 3.1 fold when the foetus is in the primary beam (80 kV,
3.0 mmAl, FSD 80, 29x20 cm exposure area). Estimating the foetus dose at
different depths by the FetDose program (Osei et al. 2003) agrees reasonably
with Tapiovaara’s et al. (1997) results. The foetal doses calculated by PCXMC
and FetDose agree well with each other as Figure 4 shows (Servomaa &
Kettunen 2004).
For an accurate determination of embryo depth, ultrasound
measurement should be performed (Osei & Faulkner 1999b, Perisinakis et al.
1999). In indirect (outside beam of view) exposure, the distance between the
foetus and the exposed area is a significant factor affecting foetal dose (Parry et
al. 1999).
Figure 4. The comparison between Damilakis, PCXMC and FetDose in calculating the
foetus dose when the foetus is in the primary field (Servomaa & Kettunen 2004).
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2.8 Theoretical Background of this Study
The Council Directive 97/43/Euratom on the health protection of individuals
against the dangers of ionising radiation in relation to medical exposure gives
attention to the special protection requirements for childhood and during
pregnancy because of higher radiosensitivity. The detriments of low-level
radiation are becoming actual and discussion in this area is quite hot. The
results of different studies are sometimes conflicting. However, there is
consensus about the importance of radiation dose optimisation every time
ionising radiation is used for medical purposes, especially with a foetus and
children. There is also consensus about the higher cancer risk due to radiation
among a foetus and children. According to the latest epidemiological studies
(Hall 2004), there might be disturbance in intelligence after rather low
radiation doses to the brain after birth. Further studies are required to prove
these results. The radiation protection organisations and European
Commission have published guidelines for the radiation protection of the
foetus and newborns. Quality assurance programs and optimisation of the
radiation dose must be carried out.
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3 Purpose of this Study
The purpose of this study was to determine how the requirements set by degree
423/2000 of the Ministry of Social Affairs and Health to protect the most
radiosensitive individuals are fulfilled by estimating the radiation dose and
radiation risk to the foetus due to the x-ray examinations of an expectant
mother and find out the practice of preventing the embryo and foetus dose and
dose estimation practices in cases where the embryo or foetus are exposed. The
second purpose was to estimate the radiation dose and risk due to the radiation
to one special group: newborns treated in paediatric intensive care unit.
The following tasks were set down to achieve this goal:
1. Determine the number of x-ray examinations of the pelvis and lower
abdomen performed on a pregnant woman in Finland
2. Determine the practice involved if the embryo or foetus has been or will
be exposed due to x-ray examination of a woman of reproductive age
2.1 Determine the practice of excluding the possibility of pregnancy when
conducting x-ray examinations of the pelvis and lower abdomen of
women of reproductive age in Finland
2.2 Determine the practice of foetus dose estimation due to the x-ray
examination of a pregnant woman
2.3 Determine the practice in guiding a pregnant woman if the foetus is or
will be exposed
3. Estimate the dose and risk to one risk group: newborns in the PICU
3.1 Estimate the dose to a newborn from a bedside chest-x-ray examination
in the intensive care unit
3.2 Determine the number of radiation x-ray examinations to each newborn
in the study period retrospectively
3.3 Estimate the total dose to these newborns retrospectively
3.4 Estimate the risk due to the total dose to these newborns retrospectively
A proposal for guidelines for good practice in the x-ray examinations of the
pelvis and lower abdomen of women of reproductive age in Finland are made
based on these results in order to prevent the foetal dose. A proposal is given for
the dose estimation of the foetus due to mothers x-ray examination.
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4 Materials and Methods
This study consists of two different materials. The first study describes and
documents the practice of excluding pregnancy in the pelvic x-ray
examinations of woman of reproductive age in Finnish radiation departments.
In addition, the practice for foetus dose estimation and responsibility for
advising the expectant mother on the radiation risk to the foetus are described.
The other study describes the current level of doses to newborns during
their first years of life retrospectively and the risk due to this dose.
These two areas are important because the risk due to the radiation
exposure to foetus and children is higher than to adults or older people. The
European Commission directive (Council Directive 97/43/Euratom of 30 June
1997) implemented in Finnish legislation by degree 423 of the Ministry of
Social Affairs and Health, emphasises the protection of children and unborn
children (Sosiaali- ja terveysministeriö 2000).
4.1 Materials
4.1.1 X-ray Examinations of Women of Reproductive Age
The first survey consists of a questionnaire (Appendix D) concerning the
number and practice of pelvic x-ray examinations of women of reproductive
age. It determines the practice of excluding the possibility of pregnancy in
x-ray examinations of pelvis and abdomen. The recording system for x-ray
examinations of pregnant women, including the possibility of recording the
technical parameters of examinations made or possibly made during
pregnancy was examined. The practice concerning the dose estimation of the
foetus due to the intentional or accidental pelvic x-ray examination of a
pregnant woman was asked. Enquiries were also made concerning the
reactions of an expectant mother to the radiation risk to the foetus.
There are about 450 safety licences for x-ray examinations in Finland
(Rantanen 2002). The same institute can have one or more licences. The
questionnaire was sent to all (290) radiation safety officers responsible for the
safe use of radiation in hospitals (district, central or university) and health
centres all over Finland (only one questionnaire was sent to each institute). The
names and addresses where taken from the radiation safety licensing registry
of the Radiation and Nuclear Safety Authority (STUK) of Finland. The
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questionnaires were signed by a research professor from STUK and by a
researcher. Prepaid answer envelopes were enclosed. The number of returned
questionnaires totalled 174 (60%); one was returned uncompleted. The number
of the acceptable questionnaires came to 173.
The questionnaires were returned from 124 (71.7%) health centres and
49 (27.1%) hospitals. Figure 5 shows that 33 (19.1%) hospitals were regional,
11 (6.3%) central and three (1.7%) were university hospitals. There were two
(1.2%) institutions where the type of institution was not mentioned. In ten
questionnaires, the radiation safety officer stated he or she was responsible for
the safe use of radiation at two or more locations. In these cases, one answer
referred to the practice at two or three health centres. The number of x-ray
institutions, if seen this way, was 187. According to Servomaa (2003), 16% of
radiation safety officers responsible for the safe use of radiation work in
2 institutions, 5% in three, 3% in four and 3% in 5–11 institutions.
Figure 5. Type and number of institutions included in the study (n=173).
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There were 114 (66%) respondents who reported some technical exposure
parameters for x-ray examinations of the pelvis or lower abdomen (mostly
pelvimetry). This information was mostly unusable because the dose could not
be calculated due to the lack of mAs values (exposes were made using AEC).
Two respondents provided information on real patient data documentation
when a foetus was exposed in uterus.
4.1.2 Radiation Dose to Newborns
The doses due to the radiographic examination of bedside chests in the
intensive care unit for newborns at Oulu University Hospital were studied; in
1998 there were 1641 x-ray examinations in the intensive care units for
children and in 1999 there were 1819 (Kylmäniemi 2001). This data included 43
newborns treated in the paediatric intensive care unit. There were 118 chest
examinations of 43 newborns in the intensive care unit at Oulu University
Hospital at the beginning of 1998 (Group 1) and in the end of 1999 to the
beginning of 2000 (Group 2). There were 27 premature infants. The gestational
age in whole data varied from 26 to 42 weeks (Figure 6).
Figure 6. The sex and gestational age of the newborns in the data recorded (n=43).
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There were 18 female and 25 male newborns with 118 bedside chest x-ray
examinations in the data collected and their exposure factors were recorded.
There were 67 (55.9%) chest ap examinations, 37 (31.4%) chest and abdomen ap
and 14 (12.7%) chest and abdomen lateral radiographs of newborns (age up to
30 days) (Table IX). Originally, there were eight different bedside chest
projections exposed in two paediatric intensive care units (because of the
incubator). The attenuation of the incubator lid (9%) was taken into account in
the dose estimation. The projections were combined into four groups: chest ap,
chest and abdomen ap (from pharynx to hip joints), chest lateral and chest and
abdomen lateral. These newborns were not exposed to chest lateral projection.
Radiographers with long experience in paediatric radiology produced the
bedside x-ray examinations made in the PICU. The weight of the newborns
varied from 0.660 kg to 5.060 kg (mean 2285 g) and their height from 31.5 cm to
57 cm (mean 43.5 cm) (Figure 7). The thickness of the newborns varied from 4.5
to 12.5 cm (mean 7.7 cm) in ap projections. The mean age of the newborns was
6.7 days (range from 0 to 35 days) at the moment of recorded exposure. The
quality of the x-ray images was assumed to be high and good enough for
making a diagnosis because experienced paediatric radiologists reported the
images.
Figure 7. The height and weight of the newborns at the moment of exposure (n=118).
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Retrospectively, the study showed that the total amount of radiological
exposure for these 43 newborns during the study came to 399. Mostly, they
were chest examination (345) made in the PICU during their first months of
life. Some chest examinations (15) were exposed in another hospital after the
baby was transported to the hospital for follow-up treatment. Other
examinations given to them were hip joints (11 exposures), bone age
(4 exposures), skull (4 exposures) and abdomen (30 exposures).
Table IX. The number of different chest projections and the weight of the newborns
at the moment of exposure (n=118).
4.2 Methods
4.2.1 Questionnaire Concerning the Practice of Pelvic X-ray Examinations
of Women of Reproductive Age and the Radiation Dose to the Foetus Due to
the Mother’s X-ray Examinations
The questionnaire was based on a valid investigation form model prepared by
STUK (Servomaa & Paile 1999) in order to record and estimate the foetal doses
due to the x-ray examinations of a pregnant woman. The questionnaire
included structured questions about the type of institute, the type and number
of x-ray examinations of the pelvic region of women of reproductive age made
in the department (questions 1, 3, 5) and the documentation of such x-ray
examinations (question 2). It included questions concerning how the possibility
of pregnancy is excluded (questions 2, 4, 12) and by who, when and how the
Weight 
(g) 
Projection 
 
 Chest ap Chest and 
abdomen 
ap 
Chest and 
abdomen 
lateral 
Total 
500–1000 16 6  22 
1010–1500 14 1  15 
1510–2000 6 2 1 9 
2010–2500 14 7 4 25 
2510–3000 5 9 5 19 
3010–3500 2 5  7 
3510–4000 4 4 3 11 
4010–5000 5 3 1 10 
5010–6000 1   1 
Total 67 37 14 118 
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estimation of the foetal dose (questions 6, 7, 8) is made. Questions were given
regarding the way the information is given to the expectant mother about the
radiation dose and radiation risk to the foetus (question 10). A question about
the final decision-maker for the x-ray examination was added to the
questionnaire (question 9). Question 11 dealt with the reactions of the
expectant mother when she was told about the radiation risk to her baby.
Question 14 included space for the technical parameters used in an x-ray
examination when the uterus is in or near the exposure field. Question 15 gave
the possibility to describe, with technical parameters, the documented
situation in the plane, fluoroscopy and computed tomography examination of a
pregnant woman. The questionnaire was tested by six radiation safety officers
responsible for the safe use of radiation in different health care organisations.
The radiation dose to the embryo was calculated using PCXMC  program
(Tapiovaara et al. 1997) and the risk due to the dose to foetus by the FetDose
program (Osei et al. 2003). The imaging technique and technical data was
estimated from the data in ten questionnaires, from the study results of Hieta
and Rautio (2000) concerning doses in lumbar spine x-ray examinations with
different image receptors and from Kettunen (1996) concerning the dose in x-
ray examinations of the chest, the hip joint and the pelvis. The data was
analysed using the SPSS 11.5 statistical program (2002). The comments were
analysed by simple content analysis (Kyngäs & Vanhanen 1999, Boyd 2001,
Boyd & Munhall 2001, Latvala & Vanhanen-Nuutinen 2001).
4.2.2 X-ray Examinations of Newborns
Permission for the data collection was applied for from the ethical board of the
Faculty of Medicine at the University Hospital of Oulu. The identities of the
newborns were not recorded on the sheets. The x-ray examinations were made
with an AMX-4 (GE Medical Systems) high frequency generator unit with
3 mmAl total filtration. Imaging plates of Agfa ADC MD-10 and MD-30 were
used as image receptors. The plates were identical in their characteristic
features and the same device was used to read them. The Dose-Area Product
meter (DAP) was fixed in front of the x-ray tube. Data recording was carried out
over two periods: January-March 1998 and November-December 1999 up to the
beginning of January 2000. The times of data collection depended on the
accessibility of the DAP meter. Summer was excluded because of the lack of the
staff. The case histories of these 43 infants were analysed in 2001. Based on the
case history and radiology form, the order of each x-ray examination in the
collected data was determined and recorded on a sheet with the patient
65
STUK-A204
number. The total number of x-ray examinations was calculated and the total
dose was estimated based on recorded data and earlier dose estimations made
by STUK (Servomaa et al. 2000a, 2000b).
To improve the reliability of the study, the first data collection was made
by one student radiographer and the latter by two radiographers. The data was
documented during the daytime because there may have been radiographers
from other units on other shifts and it would have been difficult to collect the
data reliably. The radiographers recorded each examination and each patient
on its own form, which included the date of the exposure, date of the child’s
birth, sex, height and weight. The data listed for the technique factors was
projection (chest ap or lateral, chest and abdomen ap or lateral), whether the
newborn was lying in an incubator, the thickness of the newborn, kV, mAs, the
receptor-to-focus distance, use of the grid, exposure field size on the film and
DAP. The Dose-Area Product meter system used in this study was VacuDAP
2001 with a sensitivity of >8·10-8 Gycm2. It was compared with the DAP meter
of the Radiation and Nuclear Safety Authority in Finland. The DAP reading
was corrected by a conversion factor 0.9 if the baby lied in an incubator.
In this study, the ESD was calculated by the formula:
ESD (mGy) =DAP(mGycm2)/A (cm2) ·BSF (4.2.2-1)
DAP is Dose-Area Product, A the exposure field size on the skin of the baby and
BSF the Backscatter factor.
The backscatter factor (BSF) used for children’s examinations varies
from 1.1 to 1.36 depending on exposure factors, the patient’s thickness and field
size (Harrison 1983, Jones & Wall 1985, Tapiovaara 1985, Grosswendt 1990,
Cranley et al. 1991, Schneider et al. 1992, Chapple et al. 1994, Wraith et al.
1995, Mooney & Thomas 1998). In this study, the BSF used was 1.15 for 60–78
kV with a field size of 50–330 cm2. In other cases, when the tube potential was
higher and exposed areas are wider, the BSF was 1.3.
The effective doses for the 118 examinations were calculated by PCXMC
based on the Dose-Area Product reading. For the effective dose estimation, the
skin-to-focus distance was calculated for each patient. The exposed area on the
patient’s skin was calculated separately by the known focus to image receptor
distance and the thickness of the newborn (Kettunen 1996). The effective dose
of the chest examinations with no documented technique was estimated based
on the calculated doses to the same infant. The effective dose for other
examinations (4 fluoroscopic examinations: 2 oesophagus, 1 barium meal and 1
passage and one nuclear medicine examination of bones) were estimated from
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data, based on Finnish practice, published earlier (Servomaa et al. 2000a,
Servomaa et al. 2000b).
The wide range in children’s sizes, even in infants and the effect of this on
radiographic exposure factors, complicates comparing the dose (Gallini et al.
1992). There are several classifications for age groups used for children’ dose
comparison (Gallini et al. 1992, Martin et al. 1994, Kyriou et al. 1996, Office for
Official Publications of the European Communities 1996, Schneider et al.
1998), but they were not suitable for this study. All the newborns were under
one month of age in the data collection period.
The European Union has issued guidelines on the quality criteria for
diagnostic radiographic images in paediatrics for the Entrance Surface Dose
(ESD) for children under one month of age but there are no demands for the
weight, height or thickness of the newborn. (Office for Official Publications of
the European Communities 1996.)
The statistics for the examinations of the newborns were low. The data
collection was made during two periods. The difference between these groups in
height, weight and thickness of the newborns was studied. Logistic regression
was used to find the factors affecting the effective dose of newborns in chest ap
and chest and abdominal ap projections but not in lateral view because the
group had only few observations. Multilinearity between the variances was
studied (Altman 1991, Helenius 1995, Munro 1995). The correlations between
the imaging technique, exposure area, doses or infant’s size were studied using
Pearson correlation factors.
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5 Results
5.1 The X-ray Examinations of Pelvis and Lower Abdomen of
Women of Reproductive Age
5.1.1 X-ray Examinations of Pregnant Women
The first questions concerned the statistics of the x-ray examinations
performed on pregnant women. The number of x-ray examinations performed
on a pregnant woman was not documented very well, except for x-ray
pelvimetry examinations. In 1999, 25 x-ray examinations of bones (extremities)
and sinuses, one fluoroscopy and two CTs (one in each place) were carried out
on pregnant women in eight institutions out of 173. In addition, there were
pelvimetry x-ray examinations in 26 institutions, all together 2173
examinations on pregnant women. To the question “how many x-ray
examinations of the pelvis and abdomen were made to a pregnant woman in
your hospital” produced a great number of the respondents’ comments
concerning uncompiled statistics (38 comments), no need for x-ray
examinations of a pregnant woman in a health centre (55 institutions) or
pregnant patients are sent to hospital (11 health centres).
“the question and the answer are theoretical because statistics are compiled only
for pelvimetry x-ray examinations”
“in a health centre there is no need to x-ray a pregnant woman”
“if the patient is pregnant, she is sent to the central hospital (from a regional
hospital and health centres)”
“don’t know if such examinations have been performed”
52 % (90 places) which stated that no x-ray examinations been made of the
pelvic or abdominal region of a pregnant woman, 19.7% (34 places) did not
document them and 28.3% (49 places) did not answer the question at all. In
48% of these institutions, the situation was uncertain as to whether x-ray
examinations to a pregnant woman had been performed.
X-ray pelvimetries are taken in health centres and in hospitals. Some
hospitals only carry out MRI pelvimetry. The number of pelvimetry x-ray
examinations varies widely from four examinations a year in some places up to
more than two hundred; the mean was 79.7 examinations (Table X).
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Table X. The x-ray pelvimetry examinations performed in different institutions in
1999 in this study (n=26).
Type of institution Number of 
places 
 
n 
Total number 
of x-ray 
pelvimetries 
n 
Range 
 
 
n 
Health centre 4 265 4–105 
Regional hospital 14 995 4–234 
Central hospital 7 701 15–228 
University hospital 1 212 212 
Total 26 2173  
 
5.1.2 The Documentation and Exclusion of the Possibility of Pregnancy in
Pelvic X-ray Examinations of Women of Reproductive Age
The radiographer has to check the possibility of pregnancy before the x-ray
examinations of pelvis and lower abdomen of women of reproductive age. Table
XI shows that in 61 (49.2%) health centres, the most common way of excluding
the possibility of pregnancy was to ask a woman of productive age whether she
was pregnant. In 18 cases (14.5%), the referring physician asked the same
question. Other ways were the 10 days rule with 14 (11.3%), pregnancy test as
routine 9 (7.3%) and in the same range the use of a reliable contraceptive (pills,
IUD or sterilization). In three institutions (2.4%), a poster on the wall was the
only way of checking the possibility of pregnancy. Two health centres (1.6%)
have a preliminary guide and in one case, patients fill in a written form. Three
respondents (2.4%) stated that there was no need to check the possibility of
pregnancy “because patients are nowadays very aware”. Most health centres
86 (69.4%) commented on other practices to check the possibility of pregnancy:
“if there is something unclear or the patient is unsure”. In these cases, the most
important way was to give a pregnancy test (28.2%); other important ways are
posters on the wall (9.7%) and an interview made by the radiographer before
the x-ray examination of the pelvic region.
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In 15 regional hospitals (45.5%), the most important way of excluding the
possibility of pregnancy was the radiographer’s question before the
examination about whether the patient was pregnant. In six institutions
(18.2%), they had posters on the wall or they trusted that the referring
physician had found if the woman was pregnant. The ten-day rule was in use in
two institutions. The same range was in having a pregnancy test and asking
about the possibility of pregnancy when the patient is registering for an x-ray
examination.
In all three university hospitals and six central hospitals (54.5%) the
radiographer interviews the patient about the possibility of pregnancy before
an x-ray examination. A pregnancy test, trusting the physician and a poster on
the wall are used in one place in each central hospital. Two hospitals (18.2%)
have a preliminary guide to give advice on these situations. The unspecified
institutions trust a physician’s decision. Five respondents (2.9%), (one regional
hospital and four health centres) did not answer this question at all. There are
no differences in the practices between hospitals and health centres as seen in
Figure 8.
Figure 8. The manner of excluding the probability of pregnancy in health centres and
hospitals.
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The question concerning the age a woman should be asked whether she is
pregnant produced 40 different alternatives. Four respondents did not answer
this question. There were 142 institutions that had two or more other ways as
the same alternative. The possibility of pregnancy was checked in 17.6% of the
departments (25 out of 142) and institutions (21 health centres, 1 each from the
other groups) with women aged from 15 to 50 years. In 12.7% (18 out of 142, 13
health centres, 4 regional hospitals and 1 central hospital), they asked the
possibility of pregnancy if the woman was between 15 and 45 years of age.
11.3% (16 out of 142, 7 health centres, 6 regional hospitals, two central and one
university hospital) stated that they check the possibility of pregnancy with
patients less than 50 years of age and 9.2% with women less than 45 years of
age (13 out of 142, 11 health centres and one regional and central hospital).
Females of  “fertile age” were asked if they were possibly pregnant in 8.5% of
the institutions (12 out of 142, 6 health centres, 3 regional, 2 central and 1
university hospital). Women aged 21 to 40 years were asked about the
possibility of pregnancy in 6.3% (9 out of 142, 8 health centres and one central
hospital) and women aged 16 to 45 in 5.6% (8 out of 142, 4 health centres, 3
regional and 1 central hospital). In 4.9% (7 out of 142) of health centres, they
checked the possibility of pregnancy if the patient was between 14 and 50
years. 3.5% (5 out of 142, 2 health centres and 3 regional hospitals) asked it a 17
to 50 year-old patient if she was pregnant. In 2.8% (4 out of 142, 3 health
centres and 1 regional hospital), no one was asked the question. In other cases,
there were three places each. In the rest, 31 of the 173 institutions, there were
19 different versions. The lowest age was 12 years in 4 places, 13 years in 3
institutions and 20 years in one department. The upper age varied from 35 to
55 years. The respondents from health centres and regional hospitals
commented:
“if the patient is pregnant or the situation is complicated, the patient will be sent
to the central hospital”
“It is the duty of the referring physician to ensure whether the patient is
pregnant”.
In 116 institutions (N=173), no documentation was made of whether the
possibility of pregnancy had been excluded before the x-ray examination of the
pelvic or abdominal area of a woman in fertile age. Thirteen respondents did
not answer this question. Figure 9 shows that of those 44 who documented the
presence of pregnancy, 65.9% (29 out of 44) wrote a comment (no pregnancy,
date of last menstruation) in referral, and 11.4% (5 out of 44) in the case history
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(in electronic or paper form). Two institutions (out of 44) had separate form
where the patient herself gave information on the possibility of pregnancy. The
remaining 6 institutions (out of 44) commented in the referring or case history
on whether the patient was, or probably was, pregnant. Most of the respondents
had never faced a situation when only afterwards was it noticed that the
patient was pregnant when having an x-ray examination.
Figure 9. The manner of documenting the possibility of pregnancy in different types
of institutions (n=44).
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5.1.2.1  Poster for Woman of Reproductive Age
Most of the institutions have a poster on the walls of waiting and/or dressing
rooms:
“If it is possible that you are pregnant, please notify the physician or
radiographer before your x-ray examination” (International Commission on
Radiological Protection 84, 2000).
There are no posters at all in 12 health centres and two regional hospitals. In
some cases, the reason why was explained:
“We had one earlier, but we took them away because all men said they were not
pregnant”
“no need for them because patients are so well aware”
5.1.3 Estimation of the Foetal Dose
About 80% (139 out of 173) stated that they have never been in such a situation
where they noticed that the patient was pregnant at the moment of exposure
after having given an x-ray examination of the pelvic or abdominal region
(Table XII). The respondents from 87 health centres commented:
“don’t get any feedback if such situations exist”
If an x-ray examination of the pelvic or abdominal region had been made to a
pregnant patient, the dose to the foetus was evaluated in 14.5% (25 out of 173)
of the institutions. In 58 institutions, the estimation was not made and in five
institutions, they believed that there was no need for estimating the foetus
dose.
26.6% (46 out of 173) of the respondents answered the question of who
makes the dose estimation. Figure 10 shows that radiologists in all types of
institutions mostly make the estimation. Only in four cases does physicist
make the estimation. The referring physician makes the estimation of the
foetal dose in 11 health centres. One regional hospital and two health centres
ask STUK for help.
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Table XII. The number of cases where the patient was pregnant during the x-ray
examination of the pelvic region and the pregnancy was discovered after the
examination.
Figure 10. The main estimator of the foetal dose in different types of institutions
(n=46).
 Health 
centre 
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hospital 
Central 
hospital
University 
hospital 
Unknown Total 
 n n n n n n (%) 
Once a 
year 
8 0 2 3  13 (7.5) 
Less 
often 
6 4 1   11 (6.4) 
Never 104 26 8  1 139 
(80.3) 
No 
answer*) 
6 3 0  1 10 (5.8) 
Total 124 33 11 3 2 173 
(100) 
*) no answer received 
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There was more than one person in 18 (39.1% of 46) places who made the foetal
dose estimation. Table XIII shows that in five places the radiographer was
responsible for the dose estimation together with the referring physician and in
four cases with radiologists. Radiologists and physicists were jointly
responsible in five cases.
Table XIII. The number of places where the foetal doses were estimated by more
than one estimator (n=18).
When the pelvic or abdominal region x-ray examination of pregnant woman
was needed, the dose estimation of the foetus was made in 25.4% of the
institutions. More than half respondents (56%) did not answer this question
and in addition, 14.5% stated that estimation was not made.
Figure 11 shows the timing of dose estimation and type of institution
where it was made. The foetal dose was estimated in 19.1% of the institutions
before the pelvic or abdominal x-ray examination of a pregnant woman. The
foetal dose estimation was made in seven (4% out of 173 cases) institutions
after the pelvic or abdominal x-ray examination of a pregnant woman: in three
health centres, one regional, one central and two university hospitals. In two
regional and two central hospitals, foetal dose estimation was made if the
patient asked for it. In one health centre and one regional hospital, the dose
estimation was made if required e.g. if the referring physician required it. The
respondents from four health centres and one central hospital stated that there
was no need for estimation. In two health centres and one regional hospital, the
foetal dose was estimated both before and after the pelvic or abdominal x-ray
examination of a pregnant woman.
The most important way of estimating the foetal dose was to use
literature (61.4%) or estimation based on imaging technique (20.5%) and a dose
calculation program (e.g. DAP and PCXMC) (Table XIV). In two cases, TL
dosimeters or a phantom were used. The remaining the respondents made the
estimation “based on experience” or “feeling” (it feels like this).
 Radiolo-
gist 
Physi-
cist 
Referring 
physician 
Radio-
grapher 
STUK Total 
 n n n n n n 
Radiologist  5 2 4  11 
Physicist     1 1 
Ref. 
physician 
   5  5 
STUK 1      
Total 1 5 2 9 1 18 
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Figure 11. The timing or situation of the foetal dose estimation and type of institution
(n=173).
Table XIV. The methods used for the foetal dose estimation in different institutions
(n=44).
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 n n n n n n *) 
Literature 16 6 2 2 1 27 
(15.6/61.4) 
Estimation 4 3 1 1  9 (5.2/20.5) 
Measuring 1 1    2 (1.2/4.5) 
Experience 2  2   4 (2.4/9) 
No need 1     1 (0.6/2.3) 
“Feeling” 1     1 (0.6/2.3) 
Total n **) 25 10 5 3 1 44  
 (20.2) (30) (45.5) (100) (50) (25.4/100) 
*)
 n (% of total 173 case/% places where estimation was made) 
**)
 n (% of  the group/% cases where estimation was made) 
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5.1.4 The Decision-Making Process for Performing X-ray Examinations of
Pregnant Women
The question of the decision for the need of x-ray imaging a pregnant woman in
different institutions was answered by 93.1% of the institutions (161 out of 173;
8 health centres and 4 regional hospitals didn’t give any comment). As seen in
Table XV, in the health centres the referring physician made the decision for x-
ray examination in 66 cases and the physician and radiographer jointly made
the decision in 12 cases. Radiologist and physician or patient and physician
jointly made the decision in 10 places (8.6%) and physician, patient and
radiographer together in 8 (6.9%) cases. In six health centres, radiologists
made the decision for the x-ray examination of a pregnant woman; in regional
hospitals, the corresponding share was 11 (37.9%) out of 33 and in central
hospitals, it was 2 (18.2%) out of 11 cases and in university hospitals it was 1
out of 3 cases. The other decision-makers in regional hospitals were the
physician in 6 (20.7%) out of 33 cases and radiologist and physician together in
5 (17.2%) out of 33 cases. In central hospitals, the radiologist and physician
made the decision together in 5 (17.2%) out of 11 cases. In university hospitals,
the remaining two used the radiologist and physician or the radiologist,
physician and physicist.
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Table XV. The decision-maker for the x-ray examination of a pregnant woman in
different institutions (n =161).
In health centres, the referring physician made the decision and in unclear
cases, the patient was sent to the central hospital. In hospitals, the practice was
clear during office hours but in casualty time, the radiographer took
responsibility for the decision. There were many comments and explanations in
the answers that show how complicated the situation is:
“if the physician is present, he makes the decision; in other cases, the patient and
radiographer together”
“The radiologist is asked during office hours; in casualty time, the radiographer
makes the decision on whether to take an x-ray examination”
“The physician with the trauma patient and the radiologist of the x-ray
examination of the pelvic region and CT and fluoroscopy examinations”
“Not done to a pregnant patient if the pregnancy is known”
“The radiologist asks the opinion of physician; in casualty time, it’s the
radiographer”
“In casualty time, a phone conference: physician - radiologist”
Decision 
maker 
Health 
centre 
Regional 
hospital 
Central 
hospital
University 
hospital 
Unknown Total 
 n n n n n n (%) 
Physician and 
radiographer 
12  1   13 (8.1) 
Radiologist 
and physician 
10 5 5 1 2 23 (14.3) 
Physician, 
patient and 
radiographer 
8 3    11 (6.8) 
Patient 1  1   2 (1.2) 
Physician 66 6 2   74 (46.0) 
Radiologist 6 11 2 1  20 (12.4) 
Physician, 
radiologist 
and 
radiographer 
1 2    3 (1.9) 
Patient, 
physician and 
radiologist 
1 2    3 (1.9) 
Radiologist, 
physician and 
physicist 
1   1  2 (1.2) 
Patient and 
physician 
10     10 (6.2) 
Total (n) 116 29 11 3 2 161 
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“Problematic cases are sent to the central hospital”
“The radiographer asks the patient if the referring physician is aware of the
pregnancy; if no, the patient is sent back to physician”
“The x-ray examination will be done later, if possible”
“If the patient refuses, you can’t force her to have an x-ray examination”
“Physician = gynaecologist”
“The physician, at least in principle”
“The radiographer explains the danger of x-rays; the patient and physician
make the decision!”
“Have a discussion: physician-radiographer-patient“
5.1.5 Radiation Dose and Radiation Risk to the Foetus Due to the Mother’s
Pelvic or Abdominal X-ray Examination
The foetal doses and risk to the foetus from the most common x-ray
examinations of pelvis and lower abdomen are displayed in Table XVI. The
doses were calculated using the PCXMC 4.1 program (Tapiovaara et al. 1997)
and the risk due to radiation was calculated using the FetDose (Osei et al. 2003)
program. The patient was assumed to be 165 cm tall and 65 kg in weight. The
imaging technique was taken as the average data from the questionnaire sent
to the radiation safety offices and from the studies by Hieta and Rautio (2001)
and Kettunen (1996).
The radiation risk to the foetus increases linearly with the radiation dose
(Figure 12).
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Table XVI. Average foetus doses and risks in x-ray examinations of the pelvis and
lower abdomen of a pregnant woman.
Figure 12. The radiation risk for hereditary effects, leukaemia and fatal cancer with
different doses estimated using the FetDose program (Osei et al. 2003).
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5.1.6 Information to an Expectant Mother about the Radiation Risk to the
Foetus Due to Ionising Radiation and the Mother’s Reaction
The possibility of harm or detriment to the foetus due to x-rays was explained
to the expectant mother by the physician in 18.4% (29 out of 158) or by the
physician and radiographer together in 41.8% of the institutions (66 out of 158).
The physician together with the radiologist and radiographer explained it in
17.1% (27 out of 158) of the institutions. In 8.9% cases (14 out of 158) the
radiographer, in 6.3% (10 out of 158) the physician and the radiologist together
and in 4.4% (7 out of 158) the radiographer and the radiologist explained the
risks to the expectant mother. The midwife or a registered nurse explained the
risks in 1.3% (2 out of 158) of the cases and nobody explained them in 1.9% (3
out of 158) of the cases. In health centres, the explanation was given by either
the referring physician or the radiographer or both together. (Table XVII).
Table XVII. The explainer of the risks due to the x-rays to the expectant mother in
different institutions (n= 158).
Explainer Health  
Centre 
Regional 
hospital 
Central 
hospital 
University 
hospital 
Unknown Total 
 n n n n n n (%) 
of type 
Physician 27 2    29 (18.4) 
Radiographer 9 5    14 (8.9) 
Midwife/nurse 2     2 (1.3) 
Nobody 2 1    3 (1.9) 
Physician? 
and 
radiographer*) 
60 4 2   66 (41.8) 
Physician, 
radiologist 
and 
radiographer 
9 11 5 1 1 27 (17.1) 
Radiographer 
and 
radiologist 
2 4 1   7 (4.4) 
Physician and 
radiologist 
2 3 2 2 1 10 (6.3) 
Total  113 30 10 3 2 158 
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*)  In Table XVII the question mark after the “physician and radiographer”
means that these 60 answers included comments like
“physician? or hopefully physician; don’t know” (in 50 questionnaires)
“no agreement on the practice; physician should, don’t know what the physician
discusses with the patient” (in 20 questionnaires)
“haven’t discussed the practice” (in ten questionnaires)
There was also one comment concerning fluoroscopic examinations
“In fluoroscopic examinations or if the patient is pregnant, the radiologist is
responsible for advising about the risk”
Three respondents answered that if the patient asked, the radiographer
explained; in other cases, nobody explained. In one university hospital, written
material about the practice was planned for patients and for physicians.
There was very little experience among the respondents on how a
pregnant woman reacted when she was told about the radiation dose to the
foetus and the risk due to the ionising radiation (Table XVIII). There were 21
(20.2%) respondents who had no experience of such a situation (the
alternatives were from 84 institutions, 48.6% of 173 cases). The most common
reaction was that the patient wanted more knowledge (46 cases). The next were
that the patient was frightened (24 cases) or accepted the risk (9 cases). Most of
the respondents pointed out that the answers they had given were quite
theoretical and they had no experience of real situations.
Table XVIII. The reaction of an expectant mother when she was told about the
radiation dose and radiation risk to the foetus.
Patient’s 
reaction 
Health  
centre 
Regional 
hospital 
Central 
hospital 
Univer-
sity 
hospital 
Other Total 
 n n n n n n 
Gets a fright 12 10  2  24 
Gets anxious 1     1 
Wants more 
information 
35 8 2  1 46 
No reaction 1     1 
Wants an abortion 1     1 
Accepts the risk 3 4  2  9 
Don’t want the 
exam 
2     2 
Depends on 
individual 
 1 1 1  3 
No answer 54 10 4  1 69 
Total 108 34 9 3 2 156 
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87.9% (152 out of 173) of the institutions (109 health centres, 30 regional, nine
central and three university hospitals and other of unknown types) have a
poster on the wall of the waiting or changing room (or both): “If you are or
probably are, pregnant, please, notify the staff before your x-ray examination”.
Five (2.9%) respondents did not answer. There are no posters in 12 health
centres, two regional and two central hospitals.
In 30.1% of the institutions, the x-ray examination of a pregnant woman
was always changed to ultrasound, if it was possible. “There is no need for
change” in 8.1% of the institutions, and 6.9% (12 health centres or regional
hospitals) sent a pregnant patient to the central hospital. 43.4% of the
respondents did not give any answer.
5.2 The X-ray Examination of Newborns
5.2.1 Chest X-ray Examinations of Newborns in the PICU
There were 118 chest examinations made to 43 newborns in the intensive care
unit of Oulu University Hospital in the beginning of 1998 (Group 1) and at the
end of 1999 (Group 2) up to beginning 2001. One pair of twins and two B-parts
of twins (baby B is born later than baby A) were included in the data. There
were 66 chest ap, 37 chest and abdominal ap and 15 chest and abdominal
lateral projections. Lateral chest projections were not performed.
The smallest newborn in weight was 660 g at the moment of exposure. The
weight of the newborns at the moment of exposure, sex and projections are seen
in Table XIX.
The chest and abdominal ap was always taken when the newborn had its
first chest x-ray and the chest and abdominal long lateral mostly at the same
exposure time. The chest and abdominal projections are usually taken later
only when the paediatrician requests it in order to evaluate the condition of the
infant’s abdominal region. The indication for chest and abdominal projection
was rarely seen in the diagnosis written in the patient record. Figure 13 shows
the order of the recorded chest and abdomen exposure.
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Table XIX. Examination projections, sex and weight of the newborns at the moment
of exposure.
Figure 13. The order of the exposure of the chest and abdomen (ap or lateral)
projections to the newborns (n=54).
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The main diagnosis (mentioned first in the patient record) to 23 newborns
(53.5%) was “premature infant” and to three newborns “RDS” (7%). The
remainder had different diagnoses such as “toxaemia matris” or “small weight
at birth”. The second diagnosis for 19 newborns (73.1% out of 26 cases) was
“RDS” and 18 of them had “premature infant” as the main diagnosis. These 23
premature infants were given 18 chest and abdomen ap and 5 chest and
abdomen lateral projections.
As seen in Figure 14, in 43 (36.4%) examination time the newborn
needed help with breathing and were intubated at the moment of exposure of
the chest ap and in 24 examinations (28.3%) when having a chest and
abdominal ap. The indication for 13 chest x-rays (15.3%) was “extubation” (tube
was taken away and after that the chest ap was performed).
5.2.1.1  The Imaging Technique for Chest X-ray Examinations of
Newborns in the PICU in the Recorded Data
The images were produced with a mobile AMX-4 machine. The focus-image
receptor distance was always 1m, total filtration was 3 mmAl and no grid was
used. The tube voltage in the chest ap projections varied from 66 kV to 80 kV
(mean 69.2 kV) (Figure 15). The thickness of the newborns in ap projections
varied from 5 cm to 15 cm (mean 7.7 cm) when measured by special equipment
(a ruler with branch) at the same time as the exposure was made. In chest-
lateral (n= 15) the tube potential was from 70 kV to 74 kV (mean 71 kV).
The tube voltage (kV) varied by 6 kV in ap projections taken of babies
with the same thickness.
The weight, height and thickness of the newborns having chest ap or
chest and abdomen ap projections showed significant correlation (Figure 16).
The correlation in all the data is between weight and height is r=.938, and
between the thickness and weight of the neonate r=.739. There was no
difference between sexes. The tube voltage (r=.808), the mAs-value (r=.657)
and the thickness (r=.623) of the baby correlate positively.
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Figure 14. The projections and number of chest aps to newborns and the intubation
of a newborn at the moment of exposure (n=118).
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Figure 15. Tube voltage (kV) in chest ap projections (n=103).
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Figure 16. The qualitative correlations in the height (cm), weight (cm) and thickness
(cm) of the baby and tube voltage (kV) in chest ap and chest and abdominal
projections (n=103).
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Figure 17. The correlation of the height of the exposure field in different projections
and the height of a newborn (n=118).
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The height of the exposure field correlates with the height of the newborn
lightly (r=.433) in the whole data. The correlation between the same
parameters in chest aps was r=.422 but in chest and abdomen aps r=.262. The
heights of the exposure fields for newborns with the same height inside the
same projection differed by 10 cm (Figure 17), especially in chest and abdomen
ap.
5.2.1.2  The X-ray Examinations of Small Infants
There were 72 chest exposures to newborns under 2500 g in weight. The weight
of these newborns varied from 660 g to 1740 g (mean 1657 g) and their height
varied from 31.5 cm to 43 cm (mean 40 cm). There were made from two to 23
x-ray examinations to each infant (mean 9.5 exposes). There were 13 male and
10 females. They had 51 chest ap, 16 chest and abdominal ap and 5 chest and
abdominal lateral x-rays. The gestational age was from 26 weeks to 39 weeks;
the mean was 30 weeks. They were mostly the first or second children in their
family, but the range was from first (8 newborns) to 14th in order; the mean was
2.9. One third of the ap projections were chest and abdominal projections.
If the group of the small newborns under 2000 g was examined
separately, there were still 15 newborns, eight male and seven female, left.
Their gestational age varied from 26 to 36 weeks (mean 28.8 weeks); in
14 (n=15) cases it was under 32 weeks. Five of them were the first and four the
second, one was the 14th (mean 3.27) child in the family. There were 169 x-ray
examinations made to them, ranging from 2 to 21 examinations (mean 11.3
exposures). Three quarters of the x-ray examinations were chest and
abdominal projections, which differs from the group of newborns less than
2500 g in weight. The reason for this was unclear. The height of the exposure
field in the same projection and the same height of the newborn could differ
from 3 cm up to 7.8 cm.
5.2.2 The Doses to the Newborns in the PICU
The ESD (Entrance Surface Dose) was estimated by calculating the doses for
all 118 chest x-ray exposures from the recorded data based on the imaging
technique. The range of ESD in chest ap and chest and abdomen ap (n=103)
varied from 24.8 µGy to 191.9 µGy. In chest lateral projections (n=15), the range
was from 9.9 µGy to 108.7 µGy. In Group 2, the ESD for ap projections was
higher than in Group 1, although the mean size of the newborns showed no
significant difference (p=0.02). In lateral view, there was no significant
difference in ESD between the groups (Figure 18).
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Figure 18. ESD of the chest exposure in the PICU in different projections in data
groups (n=118). (Group 1 = data recorded in 1998 and Group 2= data recorded in
1999–2000).
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The average ESD for newborns about 1000 g in weight was 41.9 µGy (n=37), to
2000 g in weight (n=30) 54.6 µGy and to 3000 g in weight (n=20) 74.7 µGy in
chest ap and chest and abdominal ap.
As seen in Figure 19, the Dose-Area Product was higher in the latter data
study both in chest ap and chest and abdomen ap but not in chest and lateral.
The effective dose for each newborn was calculated from the DAP by the
PCXMC program. The range of effective dose was wider in Group 2 (Figure 20)
than in Group 1. In Group 2, the newborns were on average 1.59 cm thicker,
830.7 g heavier and 4.6 cm longer than in Group 1. In this data, the biggest
difference in the size of the newborns was 25.5 cm in height and 4400 g in
weight.
The effective dose was higher for all projections in the second group. It
was also higher in abdomen and chest ap than in chest ap due the higher
exposure field.
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Figure 19. The Dose Area Product (DAP) mGycm2 in the PICU in different projections
(N=118). (Group 1 = data recorded in 1998 and Group 2= data recorded in 1999–2000).
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Figure 20. The effective dose of the newborns in the PICU in different chest
projections (n=118). (Group 1 = data recorded in 1998 and Group 2= data recorded in
1999–2000).
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The mean size (weight, height and thickness) of the newborns showed no
significant differences (p=0.02) between the groups but the newborns were
smaller in Group 1 (Table XX). The groups in chest lateral were too small for
statistical purposes.
As seen in Figure 21, the Entrance Surface Dose, Dose-Area Product and
effective dose correlate strongly. There was more correlation between ESD and
DAP (r=.780) than between ESD and effective dose (r=.727). The correlation
between Dose-Area Product and effective dose was highest (r=.845).
Table XX. The differences in the newborns (in height, weight and thickness) at the
moment of exposure in Groups 1 and 2*).
*)  Group 1= data collected in 1998 and Group 2 = data collected in 1999–2000.
 n Mean Standard 
deviation (%) 
Min Max 
Height (cm)      
Group 1  37 40.0 4.69 31.5 48.50 
Group 2 29 44.6 6.9 34.5 57 
Weight (g)      
Group 1 37 1629 676.2 660 3050 
Group 2 29 2459.8 1389.7 840 5060 
Thickness (cm)      
Group 1 37 6.7 1.5 4.5 10 
Group 2 29 8.3 1.7 5.5 12.5 
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Figure 21. The correlation between the Entrance Surface Dose (ESD, µGy), the Dose-
Area Product (DAP, mGycm2) and the effective dose (µSv) in the chest examinations of
the newborns (n=118).
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In small newborns (under 2500 g) the effective dose did not correlate with the
height of the newborn (r=.260) but the height of the exposure field and effective
dose showed strong correlation (r=.751). The thickness and ESD correlate
lightly (r=.562), but the range seems to be wide between two newborns of same
thickness and in the same projection (Figure 22). In the chest and abdomen, the
effective dose was higher due to the higher exposure area. In chest and
abdomen, there was more active red bone marrow (pelvis, lumber spine) in the
exposure area and the gonads were in the primary field or near to it.
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Figure 22. The correlation of the Entrance Surface Dose (µGy) and thickness (cm) of
the newborns less than 2500 g in weight.
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The absorbed dose to different organs is presented in Table XXI. The dose range
was quite large depending on the projects and the size of the newborn. The
organs located in the primary beam when having chest-x-rays (lungs and
thyroid) had the same level of doses both in chest ap and chest and abdominal
ap as well as the brains, which are never in the primary field. The dose to
ovaries, uterus and large intestine was higher when having chest and abdomen
ap. The dose to active bone marrow was somewhat higher in chest and abdomen
ap than in chest ap.
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Table XXI. Organ doses in different projections in the recorded data (n=118).
The average effective dose to newborns about 1000 g in weight was 16.4 µSv
(n=37), to 2000 g in weight (n=30) 17.8 µSv and to 3000 g in weight (n=20)
28.3 µSv in chest ap and chest and abdominal ap.
5.2.3 The Total Number of X-ray Examinations Given to the Newborns
During the Study
There were 118 recorded exposures to 43 newborns in the PICU. The total
number of exposures was counted afterwards from the patient records. The
total effective dose for each child was later estimated on the basis of the
recorded imaging technique and other available data collected by STUK
(Servomaa et al. 2000a, Servomaa et al. 2000b). If the newborn was transported
to another hospital, the hospital in question was asked for the number, type and
technical parameters of the x-ray examinations.
The total number of exposures (without possible unrecordered retakes)
was 394 (345 chest, 30 abdomen, 11 hip joint, 4 bone age and 4 skull) exposures.
There were also four barium meal examinations, including images and
fluoroscopy; one newborn was given a nuclear medicine examination.
 Average dose and dose range (mGy) 
 Chest ap Chest and 
abdominal 
ap 
Chest and 
abdominal 
lateral 
All 
projections 
Mean 
Organ (n =66) (n= 37) (n=15)  
Ovaries 0–1 0.6–57 1–41 9 
Testes 0–1 0–24 0.2–16 1 
Uterus 0.1–9 1–66 1–33 9 
Act. Bone*) 3–13 4–16 7–14 7 
Lungs 17–95 19–79 31–58 39 
Thyroid 15–150 9–89 19–86 48 
Large int.**) 3–29 1–79 2–62 16 
Brain 0.2–1.5 0.02–1 0.3–1 1 
*) active bone marrow 
**) large intestine 
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Figure 23. The total number of x-ray examinations per child during the study
(n=394).
 
The number of x-ray examinations ranged from 1 to 40 (mean 9.3) per child
(Figure 23). Five chest examinations were produced later than during the first
treatment period, after birth in hospital. Hip joints and skull examinations
were made during the first year of life. Mostly there were two to three
examinations per newborn during the study.
5.2.4 Total Effective Dose and Radiation Risk Due to the Radiation
Examinations During the Study
The estimated collective effective dose to these 43 newborns during the study
was 0,016 manSv (mean 0.4 mSv, range 0.03 mSv–3.7 mSv).
The radiation risk due to these examinations varied from 0.0015% to
0.3% per mSv per newborn. The effective doses were grouped and the risk due
to the dose in different dose range is seen in Table XXII.
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Table XXII. The estimated risk due to the examination of these newborns (based on
BEIR V and STUK 10%/Sv).
Effective 
Dose (mGy) 
Number of newborns per group Mean 
effective dose 
(mSv) 
Risk estimation 
due to the 
radiation dose 
(10%/Sv) 
 Female Male   
< 0.1 7 13 0.058 1:100,000 
0.11–0.2 5 2 0.14 1.4: 100,000 
0.21–0.3 1 6 0.25 2.5:100,000 
0.31–1 4 0 0.52 5.2: 100,000 
1–2 1 3 1.56 15.6 :100,000 
>2  1 3.68 36.8:100,000 
Total 18 25   
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6 Discussion
6.1 The radiation Dose to the Foetus Due to Mother’s X-ray
Examination
The sample collected by the questionnaires to the radiation safety officers
responsible for the safe use of radiation is representative (in spite of the low
percent of answers) because it includes small health centres and three of the
five university hospitals. The sample is a good cross-section of Finnish practice
because the distribution of the respondents represents all institutions nearly in
the same relation as in the licence registry. It was quite stunning to see how
varied the practice was and how uncertain the respondents were about the role
of the referring physician when sending a woman of reproductive age to a
radiation examination of the pelvis and the lower abdomen.
6.1.1 Pelvic and Abdominal X-ray Examinations of a Pregnant Woman
According to this study, the number of known pelvic x-ray examinations of a
pregnant woman is quite low in Finland. Perhaps it is a consequence of the fact
that 34% of the institutions did not document the x-ray examinations of a
pregnant woman and 52% were sure they were not made in their departments.
Those who recorded the examinations mostly documented pelvimetries. There
were still 4114 x-ray pelvimetries produced (Hakanen 2002); in 1996 there
were 5083 (Rannikko et al. 1997). Mostly they are made in regional or central
hospitals, but are also carried out in health centres. In one regional hospital,
33% of pelvimetry x-ray examinations were made after delivery (for the next
pregnancy) and so the foetus was not exposed. In this study, the number of
pelvimetry examinations per institution varied from 4 to 234 per year. X-ray
pelvimetry is a very highly skilled examination and if the number of
examinations is low, the radiographer does not establish a routine to produce it.
This may include the possibility of several retakes.
An x-ray pelvimetry examination is produced in the last period of
pregnancy, in weeks 36–40 (Standertskjöld-Nordenstam et al. 1988), which is
why the danger from the exposure gives a higher risk of childhood cancer. The
International Commission on Radiological Protection 84 (2000) has proposed
reducing the number of x-ray pelvimetry examinations because statistical
analysis has indicated a poor correlation between the course of labour and
pelvic measurements and it is the major single source of ionising radiation to
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the foetus. During past years, FMRI (Foetal Magnetic Resonance Imaging) has
become more popular and it is recommended instead of x-ray pelvimetry (Hata
et al. 1990, Revel et al. 1993, Garel et al. 1998, Resten et al. 2001).
Special consideration was given to pelvic and abdominal x-ray
examinations if the patient was pregnant. A pregnant patient was sent from
health centres and regional hospitals to the central hospital where experts
made the decision about an x-ray examination.
It seems that in Finland, x-ray examinations, other than pelvimetry, of a
pregnant woman are mostly examinations of extremities and sinus. In other
countries (e.g. Ardabi 2001, Pettersson et al. 2003), there are more pelvic x-ray
examinations of a pregnant women. Statistical analysis of the registers of the
pelvic and abdominal x-ray examinations to women of fertile age and the
register of the birth of children (cf. Pettersson et al. 2003) may lead to different
results than in this study. There are about 2600 lumbar spine x-ray
examinations per year in the Oulu Health Centre and 25% of them are on
women aged from 12 to 50 years (Liedes 2004), and there are about 7000 x-ray
examinations of the pelvic region in the Oulu University Hospital (Kylmäniemi
2004). Assuming that 25% of these x-ray examinations in the Oulu University
Hospital are made on women aged 12–50 years and making a comparison with
Pettersson’s study, this could mean that in one year there might be as many as
30 foetal exposures in Oulu due to the mother’s pelvic x-ray examinations.
The practice of having x-ray pelvimetry examinations should be
seriously discussed. The advantage of x-ray pelvimetry is debatable and
according to international recommendations, it should be by ultrasound or MRI
examinations (World Health Organisation 1999).
6.1.2 Avoiding the Exposure of the Foetus
This study indicates that the present practise for the x-ray examination of the
pelvic region (pelvis and the lower abdomen) of women of reproductive age in
Finland fluctuates greatly. Neither hospitals nor health centres have guides for
“good practice”. The concept of a “woman of reproductive or fertile age” is very
ambiguous. According to the International Commission on Radiological
Protection 84 (2000) “before x-ray examination, it should be determined
whether a patient is, or may be pregnant, whether the foetus will be in direct
radiation beam, and whether the procedure is relatively high dose”.
The possibility of pregnancy was secured for women “of fertile age”,
which meant strongly different age in different organisations; the lower range
varied from 12 to 20 years and the upper range from 30 to 55 years. There were
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institutions where the possibility of pregnancy in the pelvic or abdominal x-
ray-examinations of woman of reproductive age was never, or only occasionally,
checked. In most institutions, there were posters on the wall of the waiting or
changing room. In some cases, they relied on the patient’s own responsibility.
The practice for checking the possibility of pregnancy before a pelvic x-
ray examination is very heterogeneous in spite of very clear and simple
guidelines. The State STM 423 (2000) states: “A referring physician has to get
with appropriate questions the knowledge of the possible pregnancy of a
woman of childbearing age, if the foetus may be in the exposed area. If in
referral there is no comment on pregnancy, the radiographer or radiologist has
to inquire about the possibility of pregnancy before the x-ray examination is
produced.” According this study, there was no agreement of the practice
between the diagnostic radiologist departments and referring physicians
concerning pelvic and abdominal x-ray examinations of women of reproductive
age. This is alarming when taking into consideration the complex situation
regarding the practice of excluding the possibility of the pregnancy of a woman
of reproductive age who is having a pelvic or abdominal x-ray examination and
whether it is being documented. If later is apparent that the patient was
pregnant when having an x-ray examination, it is very difficult to determine
the question of responsibility if nothing is documented. The lack of
documentation causes unnecessary questions for the patient and due to these,
problems with patient’s privacy. In Finland, there are families who do not
practice contraception because of religious conviction.
There should be posters or notices on the walls of x-ray departments and
dressing rooms to inform female patients to state before an x-ray examination
if they are probably pregnant. According to State STM 423, paragraph 37:
“There have to be notices in the places adjoining the medical use of radiation
that ask patients to announce their pregnancy and breast-feeding to personnel
in order to protect the foetus and breast-feeding child”.
There is no consensus of practice how to require or document the
possibility of pregnancy and when it should be done. In some institutions, the
ten-day rule is in use in all examinations and in some institutions, they rely on
the patient’s awareness.
6.1.3 The Practice in Estimating the Foetal Dose
The practice of estimating the foetal dose seemed to be a difficult problem;
nearly half of the respondents (49.1%) did not answer this question. In
university and central hospitals the estimator was in most cases the radiologist
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and/or physicist. According the National Radiation Protection Board (2001),
the International Commission on Radiological Protection 84 (2000) and State
STM 423 (2000), the patient’s dose should always be estimated afterwards, if
needed. This means that the technical parameters of the examination must be
documented carefully. If there is awareness of pregnancy before the x-ray
examination and if the foetus is in the primary beam (or there is a lot of
scattered radiation), the referring physician and radiologist have to discuss the
necessity of the radiation procedure. If the examination is medically indicated
and cannot be delayed until after pregnancy, the dose to the foetus should be
estimated before the examination, calculated afterwards, and optimized
carefully (International Commission on Radiological Protection 84, 2000,
International Commission on Radiological Protection committee 3, 2001,
European Commission 2001).
There are data for foetal doses in different examinations e.g. in
publications by the International Commission on Radiological Protection 84
(2000), the National Radiological Protection Board (1998) and in many articles
(Claussen et al. 1985, Osei & Faulkner 1999a, Parry et al. 1999, Toppenberg et
al. 1999, Damilakis et al. 2000, Karam 2000, Mann et al. 2000, Osei & Faulkner
2000, Fenig et al. 2001, Timins 2001). They are very useful for a rough
estimation especially in low-dose examinations (cf. Table III). The foetal dose
estimation can be made on the grounds of the technical parameters of the
abdominal and pelvic region x-ray examination, by calculating the ESD, by
measuring the surface dose (TLD), or Dose-Area Product (DAP). The effective
dose of the foetus can be calculated by the PCXMC (Tapiovaara et al. 1997) or
FetDose (Osei et al. 2003) programs (cf. Table XVI). These are practical ways for
estimating the dose because it is very difficult to get a reliable dose estimation
due to the special features of a pregnant mother and the situation of the foetus
(cf. et al. 1999a, Perisinakis et al. 1999).
The foetal dose estimation should be performed before the planned x-ray
examination of a pregnant woman and the results should be conveyed to the
woman’s physician (Karam 2000) and the dose calculated afterwards if it is so-
called high dose level x-ray examination and the foetus is in the primary beam
(International Commission on Radiological Protection 84, 2000, International
Commission on Radiological Protection committee 3, 2001). In State STM 423
(2000), there is a demand that “The estimated foetal dose and the information
important for the radiation exposure due to the x-ray examination have to be
documented in the patient’s record”. For examinations other than pelvimetry,
the documentation was rarely performed in Finnish health care institutions.
101
STUK-A204
The dose estimation was done occasionally. There were no guidelines on
how to act in situations where the embryo or foetus will be irradiated or was
accidentally irradiated.
6.1.4 The Decision-Making Process for the X-ray Examinations of Pregnant
Women
According to State STM 423, the referring physician judges whether an x-ray
examination is justified based on the information available (previous x-ray
examinations, dose, risk due to radiation and benefit to the patient). If the
radiologist disagrees about the medical indications for the x-ray examination,
he has to discuss the matter with the referring physician. If the radiologist still
disagrees about the justification, the examination is not performed. Always
when the referring physician and radiologist agree of the necessity of the
exposure of the foetus, the decision has to be documented (European
Commission 2001). The patient has right to make up her mind on whether the
x-ray examination should be made; the opinion of the expectant mother has to
be taken into consideration.
In many health centres, the radiologist visits the health centre once a
week or never. This means that the referring physician and/or radiographer
made the decision for the x-ray examination of a pregnant woman. In the
hospitals, either the radiologist or physicist made the decision or they did it
together. It is notable that the patients participated in the decision-making
actively in 28% of the institutions. The comments from the respondents
expressed the complicated situation in the practice: in small health centres the
referring physician, the radiographer and perhaps patient had a discussion
and decided if the benefit of an x-ray examination of a pregnant woman is
higher than the risk to the foetus.
A pregnant woman has right to know the risks to the foetus due to an x-
ray examination. The mother was told the risks mostly by the referring
physician or the physician and the radiographer. Sometimes, the danger was
explained by the radiographer, registered nurse or midwife and sometimes the
patient was not told at all. Karam (2000) points the importance of working and
reporting within one’s own area of competence and this area needs a lot of
discussion about who has the best knowledge and whose duty it is to give
information to the patients.
There was no good practice concerning the decision-making process if a
pregnant woman was irradiated. According this study, the staff in x-ray
departments have no guidelines. The referring physician should have the
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responsibility of excluding the possibility of pregnancy, but the staff in the
x-ray department did not know if this is done. The counselling for an expectant
mother concerning the radiation risks to the foetus was unclear. This study did
not give any answer to the question who counsels the expectant mother.
6.1.5 Guidelines for X-ray Examinations of the Pelvic Region and Abdomen
of Women of Reproductive Age
Alternative investigation modalities (not involving ionising radiation) should
have been considered before a decision is made to use ionising radiation as
diagnostics in female patients of reproductive age. When an x-ray examination
of female of reproductive age is planned and the primary beam irradiates the
pelvic or lower abdominal region, she should be asked whether she is or might
be pregnant. If the patient cannot exclude the possibility of pregnancy, the
possible overdue to of her menstrual period should be asked. This should be
recorded in an appropriate place. The pregnant patient has right to know the
magnitude and type of potential radiation effects that might result from in
uterus exposure. Usually the benefit from the x-ray examination is greater
than the risk to the foetus due to radiation. For low-dose procedures the only
information that may be needed is a verbal assurance that the risk is judged to
be extremely low (e.g. chest and extremities). When the foetal dose is assumed
to be above 1 mGy, more detailed explanation and counselling is needed to help
the patient to make up her decision if the examination is produced or not. The
information should include the potential radiation risks and the harm
resulting from not having the medical procedure. (E.g. International
Commission on Radiological Protection 84, 2000).
6.2 The Examinations and Dose to the Newborns
6.2.1 The X-ray Examinations of Newborns in the PICU
In 1998, there were 1,013 and in 1999, there were 969 x-ray examinations made
in the PICU at Oulu University Hospital. (Kylmäniemi 2001). The recorded
data included 118 chest examinations made to 43 newborns. There was some
difference in the size of the newborns. In the latter group, the newborns had a
weight of 710g and a height of 3.8 cm more than in the data for 1998. The chest
and abdomen ap was always taken when doing the first chest x-ray of a
newborn and later it was taken when the paediatrician especially required it.
103
STUK-A204
In the latter data the chest and abdomen was produced more often than in the
first period. The reason for this was not seen in the patient record. The most
important medical diagnosis for premature infants was RDS, as in the study by
Sutton et al. (1998).
Both the effective dose and Entrance Surface Dose were higher in the
latter period. Probably, this was due to the thickness of the newborns and the
question of image quality. This is considered to be of primary importance in
children’s x-ray examinations because a loss of resolution is often the only
positional information required (Cook et al. 1998) and to get better image
quality, the radiation dose needs to be higher (68.4 kV =>70.2 kV; 1.39 mAs =>
1.7 mAs). (c.f. Kyriou et al. 1996).
The mean thickness of the newborns was 7.3 cm in the first data and
8.6 cm in the second data (a difference of 1.3 cm). Every 1 cm increase in a
patient’s thickness requires a 25% increase in mAs value when working
without a grid less than 100 kV and a patient thickness under 15 cm (Al-Balool
& Newman 1998). In addition, it became obvious in this study that the staff
used the thickness of the baby as the base for estimating the mAs and kV
values for exposure. This justifies the higher mAs and tube potential. When
using digital image receptors, image quality is better when using more
radiation, which is beneficial because the need for retakes due to under or over
exposure is not probable but there is a danger that doses will get higher when
seeking better image quality.
There are few studies concerning the correlation between a patient’s
weight and thickness and the ESD and DAP (Mooney & Thomas 1998).
According to this material, they correlate with each other. (Martin et al. 1994)
Wraith et al. (1995) showed a clear relationship to a patient’s weight both with
Entrance Surface Dose and Dose-Area Product, which was also found in this
study. This relationship is important to take into consideration because there
was a very wide range in the size of newborns (in weight from 0.660 kg to
5.040 kg, mean 2.285 kg and in height from 31.5 cm to 57 cm, mean 43.5 cm).
In this study, the mean value of exposures was 7.9 per child, which is
somewhat higher than e.g. in surveys by Wraith et al. (1995) mean 3.8,
Armpilia et al. (2002) mean 3.2, Chapple et al. (1994) mean 5.3 and McParland
et al. (1996) mean 4.7 but lower than in Sutton et al. (1998) mean 9.1 or
Siironen (2003) mean 14. Wilson-Costello et al. (1996) had a mean of 31
examinations and Ono et al. (2003) 25.9 with premature infants less than 750 g
in weight). Ono et al. (2003) found in their study that the number of x-ray
examinations is inversely proportional to the birth weight in the PICU.
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The variation in field size with in the same size group of newborns and in
all data was noticeable as in all other studies (Lowe et al. 1999, Cook et al. 2001,
Armpilia et al. 2002, Gogos et al. 2003). That shows how difficult it is with small
newborns to identify the real exposure area and limit the exposure area to the
optimal size. According to Jones et al. (2001), good standards of radiographic
practice are more important than the choice of technique. It seems that with
digital archive, the previous images are not in use before exposure and that the
size of the exposed area is difficult to judge.
6.2.2 The Dose Due to the Chest X-rays in the PICU
The European Commission (1996) issued reference values and guides for the
good imaging technique for chest examinations of newborns. The ESD
reference value is 80 µGy (European Commission 1996). In addition, the
National Radiation Protection Board (Hart et al. 2000) has given a reference
value for ESD that is lower (50 µGy) than the Em’s. In this data (n=118), the
mean ESD in chest ap examinations was 62.1 µGy (range 24.8–191 µGy). On
average, the ESD was lower than EU reference values but higher than the
NRPB’s. The reasons for exceeding the dose reference values maybe in imaging
technique: the thinner filtration (3 mmAl instead of EU proposal added
filtration up to 1 mmAl +0.1 or 0.2 mmCu) (European Commission 1996) (cf.
with e.g. Seifert et al. 1998, Fenner et al. 2002, Duggan et al. 2003). Parviainen
et al. (2003) found in their study made at HUCH that the average ESD of
newborns less than one month of age was a mean of 43 µGy and a DAP (mean)
of 3.4 mGycm2 but in the study by Lowe et al. (1999), the ESD ranged up to
160 µGy. Sutton et al. (1998) estimated the ESD for 498 radiographs of
newborns less than 1.5 kg (mean 1.11 kg), where the ESD varied from 15.3 µGy
to 73.9 µGy; the mean was 33.1 µGy per radiograph. In chest examinations, the
mean ESD was 31.9 µGy and in chest and abdomen, 43.7 µGy. Ono et al. (2003)
studied doses to the neonates for a birth weight less than 2.5 kg. In their study,
the range of the ESD was from 170 µGy to 720 µGy for neonates under 1 kg and
the range was from 70 µGy to 149 µGy for neonates from 1 kg to 2.5 kg.
According to several studies (Fletcher et al. 1986, Chapple et al. 1994,
Wraith et al. 1995, Kyriou et al. 1996, McParland et al. 1996, Sutton et al. 1998,
Armpilia et al. 2002, Ono et al. 2003, Samei et al. 2003, Toma 2003), the tube
potential varies from 46 kV to 70 kV and mAs from 0.4 mAs to 2 mAs. The mean
ESD per radiograph varied from 16 and 70 µGy. The results of this study agree
with those published earlier. Duggan et al. (2003) recommend a tube potential
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of 66 kVp with a 0.05 hafnium filter for chest x-ray examinations of infants
under 2 kg.
In Armpilia’s (2002) study, the weight of the newborns was from 1.1 kg to
1.7 kg (mean 1.5 kg) on average. In this study, there were 36 exposures to
newborns under 2 kg, all premature infants. Table XXIII gives a summary of
this size group, comparing it with Armpilia (2002). The most noticeable
differences are in tube potential voltage (~10 kV) and effective dose.
In the three CEC paediatric Trials in 1989–1995, the average Entrance
Surface Dose measurements from paediatric radiography in a chest ap was
0.045 mGy for a newborn weighing 1 kg, which is at the same level as in this
study (European Commission 1996). The NRPB’s (Hart et al. 2000) reference
level for newborns (without weight limits) is somewhat higher, 0.05 mGy. Table
XXIV shows the results of this study and gives examples of reduced doses with
attention to good technique in Queen Mary’s Hospital for Children (Cook et al.
1998). The ESD is much higher in all weight groups in this study but the
effective dose is lower except for the group of the smallest newborns. This may
be due to the fewer chest and abdomen examinations of the bigger infants in
weight.
Table XXIII. Summary of the study of premature infants’ (0.66 kg–1.7 kg) estimated
doses and, including radiographic data, patient data, compared with Armpilia (2002).
 Chest ap Chest and abdomen 
 This study 
range 
(mean) 
Armpilia 
average 
This study 
range 
(mean) 
Armpilia 
average 
Weight (kg) 0.66–1.7 (1.2) 1.7 0.8–1.74 (1.1) 1.1 
Thickness (cm) 4.5–7.5 (6.2)   - 6–7.5 (6.7) - 
kV 66–70 (67.6) 53.1 66–68 (67.8) 52.2 
mAs 1–1.6 (1.3) 2 1.25–1.6 (1.4) 2 
DAP (mGycm2) 1.8–6.3 (3.5) 4.3 3.6–8.1 (5.8) 5.5 
ESD (?Gy) 24.8–99.8 
(40.8)*) 
36**) 38.0–71.3 
(47.5)*) 
35**) 
Effective dose 
(?Sv)/radiograph 
7.56–27.5 
(14.1) 
7.8 18.4–43.6 
(25.9) 
9.2 
*) with BSF 
**) Without BSF 
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Table XXIV. Entrance Surface Doses and effective doses of the chest ap of the
newborns of different weights in this study and in Cook’s et al. (1998) study of a
department with good attention technique.
When both chest and abdomen radiographs are needed, a significant dose
reduction can be achieved by taking one chest and abdomen exposure instead
of two (chest and abdomen separately) because it eliminates overlapping
(Duggan et al. 2003).
6.2.3 The Total Number and Dose Per Child Due to all X-ray Examinations
During the Study
There were 398 x-ray examinations and one nuclear medicine examination
made to these 43 newborns during the study. The most common examination
was chest or chest and abdomen. Only a few skull, bone age and hip joint
examinations were produced. This is the same range as in other studies
(Wilson-Costello et al. 1996, Siironen 2003). The majority of the radiographs
were performed during the newborn period (the first month after birth). In the
study by Wilson-Costello et al. (1996), the range was same for chest
radiographs but in this study, there was no noticeable increase in the number of
abdominal exposures at a later age. In the study by Ono et al. (2003), the most
usual examinations in the neonatal intensive care unit were babygrams (chest
and abdomen) and chest but in the large data, there were also a lot of CT
examinations of head and abdomen and fluoroscopy examinations.
Weight (kg) 
 
ESD (mGy) Effective dose (mSv) 
(range/mean in 
this study) 
This study 
mean 
(range) 
Cook 
(1998) 
mean 
This study 
mean 
(range) 
Cook 
(1998) 
mean 
1 (n=37) 0.04 0.01 0.16 0.02 
(0.66–1.49/1.04) (0.03–0.1)  (0.01–0.4)  
2 (n=30) 0.06 0.02 0.02 0.04 
(1.56–2.48/2.14) (0.03–0.08)  (0.01–0.03)  
3 (n=20) 0.08 0.03 0.03 0.07 
(2.51–3.39/2.91) (0.06–0.08)  (0.01–0.05)  
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6.2.4 The Risk to a Newborn Due to an X-ray Examination
In ICRP 60 (1991), the risk of fatal childhood cancer due to pre-natal exposure
has been estimated to vary from 2.8·10-2 Sv-1 to 13·10-2 Sv-1. The authors stress
that the risk is greater during the first trimester than in later pregnancy. If it
could be accepted that the risk is same in the later periods, the risk due to
radiographs taken shortly after birth (and especially of premature infants)
should be similar as the risk of foetus. In this case, the risk of childhood cancer
from one single radiograph would be (3–13)·10-5.
For the 43 children in this study, the total effective dose to the whole
population due to x-ray examinations was 0,016 manSv and the mean effective
dose was 0.37 mSv. One child received an effective dose on 3.68 mSv due to the
nuclear medicine examination. The radiation risk of fatal childhood cancer due
to a mean dose of 0.37 mSv is 3.7·10 –5.
6.3 Reliability of the Study and Results
The reliability of the study was improved by using a tested questionnaire based
on the form model from STUK. The number of returned questionnaires was 173
(60%). Some of the respondents were radiation safety officers responsible for
the safe use of radiation in two or three places, as they stated in the returned
questionnaire (cf. Servomaa 2003). The results of the survey showed that in the
early phase there was no common practice on how to act when performing an x-
ray examination of the pelvic region on a woman of reproductive age. This led to
the decision not to send reminder letters or new enquires because it was
presumed the results would not improve. The distribution of the returned
questionnaires well represents the distribution of the hospitals and health
centres having x-ray equipment (cf. Hakanen 2002). Perhaps some institutions
did not answer because of the lack of good practice. The nature of this study was
a representative and reliable and showed a bad lack in the safe use of medical
radiation. This resulted in changing the nature of this study and a proposal for
a guide in good practice was designed.
The reliability of the study into the doses given to newborns was
improved by recording the data during the day shift and using three
radiographers. They always recorded the data thoroughly and consistently. The
patient records were analysed in the archive and they were kept anonymous.
The doses counted based on the recorded data was reliable when taking into
consideration the reliability of the DAP meter but the doses to other exposures
are estimations and only show the level of the received doses. The researcher
made the dose calculations of the ESD and effective dose by herself and the
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results of the calculations were checked twice. The risk estimation was based
on the practices of STUK, BEIR V and ICRP. Risk estimation involves
uncertainty but in this study, the risk estimation due to the radiation dose is at
the same level as it is in international studies. The results of the doses to the
newborns or the total number of x-ray examinations cannot be generalised.
They provide good reference levels for the future – for using new digital
equipment in paediatric departments and for optimising the radiation dose. A
larger number of newborns would have given results that are more reliable but
in this study, they are examples of the doses and of the number of x-ray
examinations to one risk group that should be studied more carefully. Probably,
the most ill newborns were not included in the data.
6.4 Ethical Issues
The ethical issues of this study are dual. The questionnaire to the radiation
safety officers responsible for the safe use of radiation was sent and received by
the authority on the basis of their registry. The respondents were all on duty
and one of their responsibilities was to give information to the Radiation Safety
Officer of Finland. The institutions were grouped in health centres, regional
hospitals, central hospitals and university hospitals. Individual institutions
could not be identified.
Permission to collect the data on the newborns was applied for from the
ethical board of the Faculty of Medicine at Oulu University Hospital. The
system for collecting and recording the data was designed and tested together
with the staff in the paediatric x-ray department. Dose follow-up is an
important area of quality assurance and it should be carried out annually,
which is why the permission of the parents was not sought. If the parents were
nearby, they were informed about the data recording of the doses. The problem
in paediatrics is the huge variation in the size of the patients. Some of these
newborns may also have been critically ill. This data collection did not
endanger the chance of these newborns recovering from their illnesses (cf. Laki
lääketieteellisestä tutkimuksesta 1999). The doses to the newborns had not
recently been studied and in particular, there was no retrospective study of the
doses to newborns in Finland.
Permission for the study of the patient records was applied for from Oulu
University Hospital. The patients’ records only were handled in the archive.
The patients’ records were searched according to the time they were cared for
in the PICU and on the basis of the examinations made to each child. The
exposure dates, examination and patient weight and height formed the critical
109
STUK-A204
information about the newborn. The identity of the newborn was not recorded
on the worksheets; all that was used was a consecutive number for each
newborn. An individual newborn cannot be identified from the data. The data
sheets will all be destroyed. (c.f. Brockopp & Hastings-Tolsma 2003.)
6.5 General Discussion
This study showed that there is no common practice on how to document the x-
ray examinations of a pregnant woman or to exclude the possibility of
pregnancy in x-ray examinations of a woman of reproductive age. In some
institutions, they believe that the patient is aware of the risks and informs the
staff by herself; in other institutions, the ten-day rule is in practice. Neither
was there any practice on how to act if a pregnant woman is exposed
(accidentally or on purpose). In Finland, there are families who do not use birth
control due to religious reasons and it is possible for those mothers to become
pregnant soon after an earlier delivery. In most institutions, there was no
practice or guides for foetal dose estimation. Degree 423/2000 by the Ministry
of Social Affairs and Health is quite new and probably this is the reason why as
yet there are no guidelines for good practice in this area.
According this study, nobody had taken responsibility for advising
a pregnant woman about the risk to the foetus due to x-rays. The law on
a patient’s rights (1992) as well as the STM degree 423/2000 points out
a patient’s right to participate in the decision-making process concerning her
health and illness, treatment and investigation. The referring physician should
discuss with patients about the doses due to ionising radiation and alternative
modalities. The referring physician should also exclude the possibility of
pregnancy. It was obvious, according this study, that there is not yet any good
practice. The staff of a radiological department rarely knows if the referring
physician has had the discussion and excluded the possibility of pregnancy. The
radiographer or radiologist who performs the x-ray examination also has the
duty to check the possibility of pregnancy.
To improve this practice, this study presents a proposal for a guide to
good practice in the pelvic x-ray examinations of a woman of reproductive age
(Appendix F). It includes guidelines on how to exclude and document the
pregnancy of a woman of reproductive age coming for a pelvic or lower
abdominal x-ray examination and guidelines for foetal dose estimation and
documentation (Tables III, XVI and EI, Appendix E). It will be published later
in Finnish.
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The results of this study show that the risk from one neonatal radiograph
is low. However, the benefit versus risk of each radiograph is important and
must be checked carefully. Radiation effects are cumulative and some children
may have dozens of x-rays and maybe a nuclear medicine examination. There
are also some risk groups e.g. children with vesicoureteral reflux who due to
diagnostic and follow-up examinations may receive doses of up to 11 mSv
during to the age of sixteen years (Kettunen et al. 2003) and in the study by
Fotakis et al. (2003) 0.31 (+/-0.86) mSv for male patients and 0.28 (+/-0.76) mSv
for female patients per examination to the age of five years. Another, small but
important risk group is children undergoing heart investigations. The dose
conversion factors for a 9 kg patient (1 year old child) are 1.8 mSv/Gycm2 in
frontal view and 1.4 mSv/Gycm2 in lateral view (Axelsson et al. 1999). Some of
these children may receive x-ray or nuclear medicine examinations for other
reasons and in these cases, the dose can be much higher (cf. Siironen 2003).
The wide range of doses in the PICU needs the continual assessment of
radiation dose in the neonatal nursery. The almost universal under collimation
on all sites is conspicuous. Collimation does not affect the ESD but it is very
important for effective dose reduction especially with very small newborns and
premature infants because the organs are in or very close the primary
radiation beam. Two centimetres is quite a large difference in a newborn 32 cm
in height and in an exposure area 6 cm high. However, this shows the demands
set on caring for the infants.
By making sure that only essential radiographs are taken, the staff can
optimize the radiation dose to a newborn. In addition, collimation of the
radiation beam so that only the relevant organs are in the exposure area and
the use of radiation shields are important ways of optimising the radiation dose
to newborns. In this study, these were not recorded separately because they are
always in use.
The newborns often lie in an incubator and need help with breathing and
other vital functions. It is important to maintain a stable body temperature. For
this reason, it is important to work quickly and gently when taking x-rays of a
newborn. Extra noise, an open window on the incubator or a careless touch may
course harm and pain to the baby. All this requires the radiographer producing
the x-ray examination to have high professional skill.
Digital imaging gives new possibilities to postprocess an exposed x-ray
and decrease the need for retakes or extra exposures: e.g., edge enhancement to
copies of neonatal chest radiographs helps to identify small pneumothoraces
and vascular catheters (Goo et al. 2001) and gives increased contrast and the
possibility to transfer images quickly via teleradiology to a specialised
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paediatric radiologist (Tarver et al. 1990, Pohjonen et al. 2002). Routine daily
chest radiographs may give new information to the paediatrician in 50% of the
cases of very low birth weight infants (Greenough et al. 2001). According to
Oeppen et al. (2002), “the chest x-ray is not recommended in the initial
evaluation of the asymptomatic neonate with heart murmur”. This data was
collected at the end of the 1990s. The equipment is still the same. Dose
optimisation is made all the time. According to the study by Siironen (2003), the
doses are at the same level today.
The latest results of the Swedish study (Hall et al. 2004) into the effects
of radiation dose to the brains of infants are alarming. Intellectual
development can be disturbed if the infant’s brain is exposed to ionising
radiation at doses equivalent to those caused by head computed tomography.
The use of radiation must be considered carefully and the use of MRI instead of
CT is important. The need for retrospective studies into the influence of the
radiation dose from all radiation examinations even at the individual level is
obvious. The importance of radiation dose optimisation sets new challenges on
the training of radiographers. According to Chan et al. (1999), it is possible to
get a reduction of 40% in radiation dose in cranial CT, and according to Ratcliffe
et al. (2003) 50% in a paediatric pelvic CT, without the loss of image quality. If
the CT parameters used for paediatric patients are not adjusted on the basis of
examination type, age and/or size of the child, the doses are unnecessarily high.
In the study by Pages et al. (2003), one unit had same protocol in head CT for
adults and children and this resulted in an effective dose of 17.1 mSv to a five
year old and 10.5 mSv to an adult. Dose estimation and dose optimisation in CT
is constantly becoming more reliable (e.g. Chapple et al. 2002, Akahane et al.
2003). Helical and multi slice CT offers great possibilities for imaging children
but its sensible use requires good communication and consultation between the
paediatrician and radiologist. One important strategy for minimising the
radiation dose to children is to limit the number of CT examinations by
evaluating the appropriateness criteria for the CT examinations of children
(Frush et al. 2003).
Adequately trained radiographers should perform the examinations on
newborns and children. Together with the radiologist, they can maximize dose
optimisation without losing good image quality.
This study has raised many aspects for new tasks to be studied.
A statistical analysis of the registers for the pelvic and abdominal x-ray
examinations of women of fertile age and the register for children born could
produce new information (cf. Pettersson et al. 2003). There are no studies
concerning the information given by a referring physician to a woman of
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reproductive age. Neither is it known how often and the way in which the
referring physician uses the knowledge of the radiation doses and alternative
imaging modalities and if Radiation Protection 118 (the guide for sending a
patient for an imaging examination) is widely spread and in every day use.
The increased use of CT and MDCT (multi slice CT or multi detector CT)
produces high dose examinations (e.g. UNSCEAR 2000, Pages et al. 2003). New
routine examinations are produced for such things as appendicitis and for
trauma patients (Berland & Smith 1998, Frush 2002). There are a lot of dual
phase (pre and post contrast) CT examinations. CT scans are retaken to ensure
the diagnosis or for the follow-up to treatment. Optimisation of the imaging
technique, especially in the CT examination of children, should be made by
decreasing the number of slices, using a low-detail setting when possible (tube
current) and setting clear indications that make it easy to produce the scan.
There are not yet reference levels for children’s doses in CT.
New imaging receptors (imaging plates and flat panels) offer new
possibilities to decrease a radiation dose but this demands a lot of work. The
image quality should be good enough, not the best. This means that all x-ray
examinations are made individually based on the patient and the information
about what the referring physician is looking for. The optimisation of the
imaging technique with digital receptors needs a slightly different practice
than optimising the dose with film-screen combination. New knowledge and
studies are required to achieve the best quality with a minimum dose.
Accurate measurement of the radiation doses to children can be difficult
because the doses are rather low, which is why the dose measurements and
dose estimation must be done very carefully. The choice of dose descriptor and
its extrapolation to radiation risk need careful consideration. The risk factors
for different stages of infancy and childhood may be considerably different from
the risk factors of the whole population. Retrospective studies of the doses or
follow-up studies of the radiation doses for some risk groups could be useful in
estimating the risk due to radiation. A paediatric radiation logbook could be
useful.
This study may help a radiological department to get good practice in the
pelvic x-ray examinations of a woman of fertile age. To get more information
about the reactions of an expectant mother in these situations, a new study
based on interviews should be performed. In addition, a follow-up study of
children irradiated in uterus would give interesting information. The risk
groups should be found and special attention should be paid to the dose
optimisation in their x-ray examinations.
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One interesting and important area for study is the dose estimation to
the foetus. It should be done, but who has duty to do it? Will it in future be one
competent area of radiographers, who have studied medical physics and
radiation protection in their further studies in university? Dose estimation is
also very problematic in health centres where there is no physicist, not even
a radiologist.
This study has raised many new thesis ideas for radiographer students,
as seen above. This study clearly shows how important it is to train
radiographers. Dose optimisation and guidelines for good practice in the
radiation field need a lot of work. Radiographer students can also inform
clinical departments about their new ideas. It is obvious that more multi
professional co-operation is needed in training health care professionals in all
fields of activity.
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7 Conclusions
The requirements set in Degree 423/2000 are not totally fulfilled in Finnish
practice.
I The number of x-ray examinations of a pregnant woman was not found
because the institutions did not document such cases or they stated that
such examinations have not obviously been produced. Only x-ray
pelvimetry examinations were documented.
II There was no common practice in Finland for excluding the possibility of
the pregnancy of females of reproductive age when having an x-ray
examination of the pelvic or lower abdomen region. The “reproductive
age” is unclear. Neither is there agreement about the practice of by who,
when and how the dose to the foetus due irradiation is estimated nor who
counsels the expectant mother about the radiation risk to the foetus.
About 50% of the institutions had no methods or practice for foetal
radiation dose estimation and their opinions were that they did not need
any methods because they did not x-ray a pregnant woman.
III The effective dose to the newborns (gestational age from 26 weeks to 42
weeks, mean 34 weeks) in the PICU due to radiological examination was
on average 7.81 µSv per radiograph. The mean ESD was 0.159 mGy
(range from 0.008 mGy to 0.16 mGy) per x-ray examination and the
mean DAP was 8.54 mGycm2 (range from 1.8 mGycm2 to 27.9 mGycm2).
Chest and abdomen projection was always performed during the first
exposure but also later. The height of the exposure area varied widely in
the same projection with the newborns of same height. About 36% of the
newborns needed help with breathing and quite often, a chest x-ray was
performed after extubation.
IV The mean effective dose to these newborns due to all radiological
examinations during the study was 0.37 mSv per child. There was some
uncertainty in estimating the risk of cancer. Recent studies have shown
other detriments to children due to irradiation. The children may receive
many x-ray examinations, which is why dose optimisation must be
performed every time. The total radiation dose should be followed up,
especially with children and young patients.
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V The radiation risk is rather low. The risk due to a mean effective dose
0.37 mSv is 3.7·10–5.
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APPENDIX A: SCHEMATIC OVERVIEW OF EXCLUDING THE PROBABILITY OF
PREGNANCY
(Adopted from the European Commission 1998, Radiation Protection 100).
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APPENDIX B: AN INFORMATION POSTER TO WOMAN IN REPRODUCTIVE AGE
An information poster on the wall of the radiological department to capture the
attention of a woman of reproductive age to advise her to announce the
possibility of ther pregnancy before an X-ray examination.
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APPENDIX C: NORMALIZED CONCEPTUS DOSES IN ABDOMEN AP AND PA
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APPENDIX D: QUESTIONNAIRE TO THE RADIATION SAFETY OFFICERS
Lisätietoja antavat: Anja Kettunen, 08-5401634 E-mail:anja.kettunen@oamk.fi, Professorintie5, 90220 Oulu 
                                    Antti Servomaa 09-759881  E-mail:antti.servomaa@stuk.fi, Laippatie 4, 00881 Helsinki 
Selvitys raskaana olevien naisten röntgentutkimuksista 
 
Säteilyn käytöstä vastaava johtaja 
 
Sosiaali- ja terveysministeriön säteilyn lääketieteellistä käyttöä koskevassa asetuksessa 
(423 / 2000) kiinnitetään erityishuomiota raskaana olevien naisten röntgentutkimusten 
säteilysuojeluun ja altistuksen optimointiin. Tämän tutkimuksen tarkoituksena on arvioida 
suomalaista käytäntöä ja verrata sitä annettuihin suosituksiin. Toivomme Teidän 
vastaavan liitteenä oleviin kysymyksiin sairaalanne osalta. Liitteenä olevalla 
tietojenkeruulomakkeella (LOMAKE 1) selvitetään, kuinka raskauden mahdollisuus 
yleensäkin varmistetaan / suljetaan pois fertiili-ikäisiltä naisilta, kuinka sikiön säteilyaltistus 
määritetään, mitkä ovat tavallisimmat raskaana olevalle naiselle tehtävät tutkimukset sekä 
millainen tutkimusprotokolla ja -tekniikka niissä on. 
 
Liitteessä on mukana myös Säteilyturvakeskuksen laatima lomake "Raskauden aikainen 
röntgentutkimus" (LOMAKE 2) annoslaskennassa tarvittavien tietojen dokumentointia 
varten. Mikäli sairaalassanne on jo aiemmin dokumentoitu raskaana olevalle tehdystä 
röntgentutkimuksesta tutkimustietoja, toivomme Teidän täyttävän lomakkeen tiedot 
mahdollisimman tarkoin po. tilannetta vastaavaksi. Tietoja käytetään arvioitaessa 
tutkimuksesta sikiölle aiheutunutta säteilyaltistusta. 
 
Pyydämme palauttamaan molemmat lomakkeet kirjeen mukana olevassa kirjekuoressa 
17.12.2000 mennessä. Tiedot käsitellään ehdottoman luottamuksellisesti ja yksittäiset 
vastaukset jäävät vain tutkijoiden tietoon. 
 
Vastaamme mielihyvin kysymyksiinne. 
____________________  _____________________ 
Anja Kettunen, THM,   Antti Servomaa, dos.  
Yliopettaja    Laboratorionjohtaja 
Oulun Seudun Ammattikorkeakoulu  Säteilyturvakeskus 
Oulun Yliopisto, Lääketieteellinen  
tiedekunta 
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      LOMAKE 1(6) 
Rastita mielipidettäsi / osastonne käytäntöä vastaava numero / vaihtoehto tai kirjoita 
vastauksesi sille varattuun tilaan. 
terveyskeskus ___ aluesairaala ___ keskussairaala___yliopistosairaala__ 
1. Kuinka monta lantion ja  vatsan alueelle kohdistuvaa röntgentutkimusta sairaalassanne tehtiin 
raskaana oleville äideille 1999?  
 
________ tutkimusta, joista _______ natiivi-,  ________  pelvimetria-,  ______ läpivalaisu- ,   
 
________ tietokonetomografiatutkimuksia, joku muu, mikä ____________________. 
 
Ko. tutkimuksia ei tehty  ___________, ko. tietoa ei ole dokumentoitu   ___________. 
 
2. Kuinka sairaalassanne raskauden mahdollisuus varmistetaan / suljetaan pois ennen vatsaan tai 
lantioon kohdistuvaa röntgentutkimusta fertiili-ikäiseltä naiselta? 
_____________________________________________________________________________ 
_____________________________________________________________________________ 
 
3. Minkä ikäisiltä  naisilta sairaalanne röntgenosastolla kysytään raskauden mahdollisuutta ? 
___________________________________ -vuotiailta 
 
4. Miten tieto raskauden mahdollisuudesta / poissulkemisesta röntgenosastolla dokumentoidaan? 
_____________________________________________________________________________ 
_____________________________________________________________________________ 
 
5. Arvioi, kuinka usein tulee lantion tai vatsan alueelle kohdistuneen röntgentutkimuksen jälkeen 
ilmi, että potilas olikin raskaana tutkimusta tehtäessä? 
Keskimäärin  _________ kertaa kuukaudessa / vuodessa (alleviivaa ajanjakso).  
 
6. Raskaana olevalle tehdyn lantion tai vatsan alueen röntgentutkimuksen yhteydessä sikiön 
säteilyaltistuksesta tehdään  ________ ei tehdä  __________arviota. 
Jos arvio tehdään, niin kuka arvioi sikiön säteilyaltistuksen po. tutkimuksessa?  
1. Radiologi                  
2. Sairaalafyysikko       
3. Lähettävä lääkäri      
4. Röntgenhoitaja         
 5. Joku muu, kuka         
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7. Milloin sikiön säteilyaltistus arvioidaan? 
 1. Ennen röntgentutkimuksen suorittamista    
 2. Tutkimuksen jälkeen     
 3. Annosarvio tehdään potilaan kysyessä annosta   
 4. Annosarviota ei tehdä    
5. Muulloin, milloin  _______________________________________________ 
 
8. Miten sikiön säteilyaltistuksen arviointi suoritetaan? 
 1. Kirjallisuuteen perustuen       
 2. Laskennallisesti                       
 3. Mittaamalla (esim. TLD, fantomi)  
 4. Muuten, miten _________________________________________________ 
 
9. Kuka päättää viimekädessä, tehdäänkö  raskaana olevalle röntgentutkimus vai ei? 
 1. Lähettävä lääkäri                   
 2. Radiologi    
 3. Säteilyn käytöstä vastaava johtaja   
 4. Röntgenhoitaja   
 5. Fyysikko    
 6. Potilas itse    
 7. Joku muu, kuka___________________________________________________ 
Tarvittaessa lyhyt selvitys käytännöstä: 
______________________________________________________________________________
____________________________________________________________________________ 
 
10. Kuka kertoo raskaana olevalle äidille röntgentutkimuksesta aiheutuvasta säteilyriskistä? 
 1. Lähettävä lääkäri    
 2. Radiologi     
 3. Säteilyn käytöstä vastaava johtaja   
 4. Röntgenhoitaja    
 5. Fyysikko     
 6. Kätilö / sairaanhoitaja    
 7. Annetaan potilaalle kirjallista materiaalia   
 8. Joku muu, kuka  ___________________________________________________ 
 9. Ei kukaan   
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11. Miten raskaana oleva äiti reagoi kuullessaan odottamansa lapsen  säteilyaltistuksesta ja siitä 
lapselle koituvasta riskistä?  
 1. Pelästyy    
 2. Ahdistuu    
 3. Haluaa tietää enemmän asiasta   
 4. Ei reagoi mitenkään    
 5. Suhtautuu välinpitämättömästi  
 6. Halua raskauden keskeytyksen  
7. Muuten, miten ___________________________________ 
 
12. Onko  odotus- ja pukeutumistiloissa tiedotettu mahdollisen raskauden ilmoittamisesta 
henkilökunnalle ennen röntgentutkimuksen suorittamista? 
 Kyllä _______ Ei _______ 
 
 
13. Kuinka usein ja millaisissa tilanteissa raskaana olevan lantion tai vatsan alueen 
röntgentutkimus muutetaan ultraääni- tai magneettitutkimukseksi? 
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________ 
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Toivomme Teidän vielä antavan seuraavat tutkimustekniikkaan liittyvät tiedot sikiön 
säteilyaltistuksen arvioimiseksi. Tutkimustekniikkaan liittyvät tiedot voivat olla joko todellisia 
raskaana olevalle potilaalle käytettyjä, tai ellei sellaisia ole, raskaana olevalle todennäköisesti 
käytettävät ("ohjearvot") kuvausparametrit ja tutkimusprotokolla. 
 
14.1 Raskaana olevalle äidille tehtävän natiiviröntgentutkimuksen tai urografian projektiot ja 
kuvausparametrit ovat tyypillisesti: 
Tutkimus ja projektio Tutkimuksen 
indikaatio 
kV mAs kenttäkoko cm2  
filmillä (leveys x 
korkeus) 
DAP (mGycm2) 
lanneranka   AP      
lanneranka   sivu      
LV      
lantio      
lonkan AP      
lonkan lauenstein      
lonkan axiolateraali 
("läpiammuttu") 
     
pelvimetria interspina      
pelvimetria sivu      
häntäluu      
sacrum      
S-I-nivelet      
natiivimaha      
urografia, iso AP      
urografia, munuaisten 
kohta 
     
urografia, viisto      
urografia, rakkokuva      
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14.2 Toivomme, että kuvailisitte alla olevaan tilaan raskaana olevalle äidille lantion tai vatsan 
alueelle tehtävässä läpivalaisututkimuksen indikaation sekä  käytettävät projektiot, 
kuvausparametrit, läpivalaisuajan sekä mahdollisesti tutkimuksessa potilaalla käytettävät 
lyijykumisuojat ja niiden sijainnin: 
Passage:_______________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
 
Colongrafia:_____________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
 
Angiografia ( mikä?) 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
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Muu tutkimus / toimenpide, jossa läpivalaisua: 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
_______________________________________________________________________ 
 
14.3 Toivomme, että kuvailisitte alla olevaan tilaan raskaana olevalle äidille lantion tai vatsan  
alueelle tehtävässä tietokonetomografiatutkimuksessa käytettävät kuvausparametrit: kV, mAs, 
leikkeiden paksuus ja lukumäärä, kuvausalue sekä mahdollisesti varjoainetehostuksen käytön 
 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
_____________________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________ 
Kiitos! 
1 6 6
STUK-A204 QUESTIONNAIRE TO THE RADIATION... APPENDIX D
   
Lisätietoja antavat: Anja Kettunen, 08-5401634 E-mail:anja.kettunen@oamk.fi, Professorintie5, 90220 Oulu 
                                    Antti Servomaa 09-759881  E-mail:antti.servomaa@stuk.fi, Laippatie 4, 00881 Helsinki 
      LOMAKE 2(3) 
15. Raskauden aikainen röntgentutkimus  
    
Mikäli sairaalassanne on jo aiemmin dokumentoitu raskaana olevalle tehdystä 
röntgentutkimuksesta tutkimustietoja, toivomme Teidän täyttävän lomakkeen tiedot 
mahdollisimman tarkoin po. tilannetta vastaavaksi. 
  
Sairaala- ja potilastiedot: 
 
Sairaala:     
 
    
Potilastiedot: Ikä ________ Pituus _____ Paino ______  
Raskausviikko ____________    
Tutkimus: Natiivi ___ Läpival_____ TT _____ Muu _____ 
 
 
15.1 Natiivitutkimus: 
 
Röntgenlaite: 
 
 
___________________________________________________ 
Tutkimus/projektio*  
 
Kuvausarvot: FFD ____ Suod. _____ kV _____  mAs _____ 
 
    
 
Kenttäkoko filmillä     _____ Annos (jos mitattu)          _____ 
 
  
Sikiö 
primäärikeilassa 
Kyllä_____ Ei _____  
 
   
Kuva 
tutkimuskohteesta 
Piirrä tarvittaessa kentän sijainti lomakkeen takana olevaan 
kuvaan 
 
 
Tutkimus/projektio*  
Kuvausarvot: FFD _____ Suod. _____ kV _____  mAs _____ 
 
    
 
Kenttäkoko filmillä     _____ Annos (jos mitattu) _____ 
 
  
Sikiö 
primäärikeilassa 
Kyllä_____ Ei       _____  
 
   
Kuva 
tutkimuskohteesta 
Piirrä tarvittaessa kentän sijainti lomakkeen takana olevaan 
kuvaan 
 
 
*Tiedot jokaisesta projektiosta erikseen (jatka tarvittaessa kääntöpuolelle) 
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15.2 Tietokonetomografiatutkimus:    (2/3) 
 
Röntgenlaite:     
 
    
Tutkimus:   Leike _____ Spir./ helical  _____ 
     
Tutkimuskohde:     
     
1) Tutkimustekniikka*: kV ____  mAs / pyörähdys       _____ 
 
    
 
Leikkeiden lukumäärä tai 
kokonais- mAs        _____
 
Leikepaksuus           _____ 
 
  
 
Leikkeiden välinen siirto    ______________             
 
  
Sikiö primäärikeilassa Kyllä ___ Ei       _____   
 
   
Kuva 
tutkimuskohteesta: 
Piirrä tarvittaessa kentän sijainti lomakkeen takana olevaan 
kuvaan 
 
 
2) Tutkimustekniikka*: kV ____  mAs / pyörähdys          ____ 
 
    
 
Leikkeiden lukumäärä tai 
kokonais- mAs         ____ 
 
Leikepaksuus               ____ 
 
  
 
Leikkeiden välinen siirto     ______________ 
 
  
Sikiö primäärikeilassa Kyllä ____ Ei     ____   
 
   
Kuva 
tutkimuskohteesta: 
Piirrä tarvittaessa kentän sijainti lomakkeen takana olevaan 
kuvaan 
 
 
* Jokaisesta leikesarjasta (natiivi, varjoaine) tiedot erikseen 
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15.3 Röntgenläpivalaisututkimus:     (3/3) 
 
Tutkimus/Projektio     
 
    
Tutkimusarvot:     
     
Kuvaus*: Kuvien lukumäärä _____ FFD  _____ Suod. _____ 
 
   
 
kV    _____ mAs  _____ 
 
  
 
Kenttäkoko filmillä ____________________ 
 
 
 
Annos (jos mitattu) ____________________ 
 
 
Sikiö 
primäärikeilassa 
 
Kyllä _____ 
 
Ei      ______ 
 
  
Läpivalaisu**: kV    _____ mA _____ Lpv-aika  _____ Annos _____ 
 
    
Sikiö 
primäärikeilassa 
Kyllä _____ Ei      _____ 
 
  
Kuva 
tutkimuskohteesta:
Piirrä tarvittaessa kentän sijainti lomakkeen takana olevaan 
kuvaan 
 
 
*Tiedot jokaisesta projektiosta erikseen, jos mahdollista, muuten keskimääräiset tiedot 
**Keskimääräiset tiedot, jos tarkkoja tietoja ei ole käytettävissä 
 
15.4 Muu tutkimus  
(Käytä soveltuvin osin edellisiä taulukoita) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
KIITOS VASTAUKSISTANNE! 
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APPENDIX E: ESTIMATED FOETAL DOSES FOR THE CT
Table EI. Estimated foetal dose for the CT of the abdomen or pelvis with the foetus in
the primary beam by 120 kVp, slice thickness 5 mm or more
If the slice is 3 mm, the increase in dose is 10–20%; for a 1 mm slice, the
increase is 30–40% and 0.5 mm slice 50–150% depending on the manufacturer.
Multi-slice helical CT(4 detector) Single helical CT 
technique Dose mGy technique Dose mGy 
300 mAs, pitch 4.5 35 300 mAs, pitch 1 35 
300 mAs, pitch 6.5 25 300 mAs, pitch 1.5 25 
200 mAs, pitch 4.5 23 200 mAs, pitch 1 23 
200 mAs, pitch 6.5 15 200 mAs, pitch 1.5 15 
150 mAs, pitch 4.5 17.5 150 mAs, pitch 1 17.5 
150 mAs, pitch 6.5 12.5 150 mAs, pitch 1.5 12.5 
(El-Khoury & Madsen 2003) 
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APPENDIX FA: PROPOSAL FOR A GUIDE TO GOOD PRACTICE IN THE X-RAY
EXAMINATION OF THE PELVIS AND LOWER ABDOMEN OF REPRODUCTIVE AGE OR
FOR A PREGNANT PATIENT
General principles
Both the foetus and children are more radiosensitive than adults are. The main
consequence following in-utero or childhood exposure at a few or a few dozen
doses typical in the diagnostic use of radiation is cancer induction. The utero
radiation risks can be compared with natural spontaneous risks. For example,
the natural cumulative risk of fatal childhood cancers in England and Wales to
the age 15 years is about 7.7·10-4(National Radiological Protection Board
1993a) and approximately 73% of all human conceptions abort before the 6th
week of gestation (Mole 1979, Boklage 1981).
X-ray pelvimetry examinations should be reduced and replaced with
MRI. If there is no possibility of MRI, the imaging technique has to be
optimised properly. X-ray pelvimetry should be performed only with a strong
indication.
In addition, other x-ray examinations should be considered carefully
when the patient is a woman of reproductive age. Alternative techniques not
involving ionising radiation should be considered before a decision is taken to
use ionising radiation. The imaging technique and the number of exposures
should be optimised and lead shields should be used when possible to shield the
radiosensitive organs.
Posters or bulletins with a picture of a pregnant mother and an
informative text should to be placed on the walls of every x-ray department
waiting room and dressing room to tell female patients aged from 12 to 50 years
that they should inform the staff before an x-ray examination if she feels she
may be pregnant (e.g. menstrual period is overdue) or she is trying to become
pregnant or she is sure she is pregnant. The text should be both in Finnish/
Swedish and in English (Appendix II). It should be stressed in the patient
information that the MOST IMPORTANT thing a patient can do is to tell to her
doctor if she is pregnant or thinks she might be. The symptoms of pregnancy
are such things as nausea, vomiting, breast tenderness or fatigue. The patient
has the right to participate in the decision-making process concerning whether
to perform the x-ray examination.
The radiographer should be very tactful when the patient is a young girl.
If her parents are nearby, she should be asked the question about her possible
pregnancy in a separate room in order to get a reliable answer.
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Always, when producing radiological procedures involving exposure of
the lower abdominal or pelvic regions of women of reproductive age, the
radiographer or radiologist must ensure that the radiation dose received is as
low as practicable. The exposure technique, projection (ap/pa) and number of
exposes (including retakes) have to be documented in all pelvic or abdominal x-
ray examinations of woman of reproductive age (as well as in all other
examinations of every individual).
It can be assumed that women who have been sterilised are not
pregnant. It must be stressed that the use of an oral contraceptive pill or
intrauterine device does not guarantee non-pregnancy. Therefore, whether a
woman of reproductive age is or may be pregnant and whether the foetus is in
the direct beam and the procedure is relatively high-dose should be determined
before all x-ray examinations. If the patient is unconscious or too sick to
answer, the radiographer should ask the family or attending physician. If the
answer is not a clearly negative “no”, and if time permits, a pregnancy test
should be performed.
In emergencies, if the female’s life is in a danger, immediate action must
be taken. In such cases, it is especially important that the risk to the unborn
child be estimated after the examination in order to provide further
considerations.
Before Irradiation
Radiation doses due to most radiological procedures present a rather small risk
to the embryo or foetus. For examinations above the abdomen or below the hips,
the pregnant patient should be assured that there is no scientific evidence that
the radiation dose due to the examination will result in any detectable harm to
the foetus. Shielding the abdomen and pelvis with lead aprons should be used.
If the foetus will be in direct beam or near it, the x-ray examination
should be delayed until after the pregnancy. The prescriber as well as the
practitioner (radiographer or radiologist) should be involved in optimising the
dose to the foetus. If the patient documents make no mention that the
possibility of pregnancy has already been checked by the practitioner in very
recent past, the radiographer or radiologist should ask the every female patient
of reproductive age orally or in written form about this before giving an x-ray.
The answer should be documented in the patient record. The recommended
manner is to give to a patient coming to an x-ray examination of the pelvic
region or lower abdomen a form to fill in, sign and return to the radiographer
before the x-ray examination (Appendix E). The forms should be archived at
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least for two years in the radiological department. If the patient is not sure that
she is or might be pregnant, she should be treated as if she were pregnant.
If the patient is or may be pregnant and the embryo or foetus may be
exposed, the referring physician must ensure that the benefit from the
examination is greater than the risk to the embryo or foetus and that earlier
examinations and other possibilities to examine the patient have been
deliberated upon.
The foetal dose must be estimated if the foetus is in the direct beam (x-
ray examination of pelvis or abdominal region). In low-dose (under 10 mSv)
examination, the foetal dose can be estimated on the basis of literature (Tables
III, IV, VII and Appendix E) during the first two months of pregnancy. The
foetal dose is also cumulative and increases the risk of fatal cancer to the child
up to the age of 15 years. The referring physician has to inform the expectant
mother about the risk to the foetus due to radiation. The patient makes the
final decision about whether to perform the x-ray examination.
In high-dose examinations (CT and barium enema), the ten-day rule
should be applied or a pregnancy test performed.
During the X-ray Examination
If an x-ray examination of the pelvic or abdominal region is performed on a
pregnant patient, the imaging technique and number of exposes have to be
optimised carefully. The imaging technique (projection, field size, number of
films for each projection, kVp, mAs, and the filtration of the unit used) has to be
documented. The beam collimation must be done carefully and appropriately to
the very specific area of interest. Removing the anti-scatter grid and increasing
kVp can reduce the foetal dose. Pelvic shielding should be used if possible.
Fluoroscopy should be limited to be as short as possible and all fluoroscopic
procedures must be timed. A written record of the fluoroscopy time, kVp and
mA, use of grid, geometrical description, projections and exposures must be
made. If the Dose-Area Product meter is in use, the dose should be recorded.
Repeat exposures must be eliminated and retakes should not be taken before
consulting the radiologist. For CT examinations, the mAs and kV should be
reduced to the lowest level and taking into consideration the diagnostic quality.
The slice thickness should not be less than 5 mm.
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After Irradiation
In x-ray examinations with a foetal dose 10 mSv or more (CT-, barium-enema,
interventions with fluoroscopy and uterus in or near direct radiation beam),
the radiation safety expert can make the dose calculation after the x-ray
examination. The foetal dose must be recorded in the patient record.
All cases of the accidental irradiation of a foetus or embryo should be, for
the sake of all concerned, documented in institutions and reported to STUK.
The risk rarely justifies the termination of a pregnancy.
174
STUK-A204
APPENDIX FB: A SHEET FOR EXCLUDING THE POSSIBILITY OF PREGNANCY
 
A sheet for excluding the possibility of pregnancy in a woman of reproductive age 
(12–50 y) coming to an x-ray examination of the pelvis or lower abdomen 
 
Consent for the x-ray examination of woman of reproductive age coming to an x-ray 
examination of the pelvic region or lower abdomen 
 
(Patient confirming that she is not pregnant) 
 
Patient’s name _____________________________________________ 
 
Date of birth _____________________________________________ 
 
Are you pregnant?   Yes________  No__________ 
 
What kind of contraceptives do you use? 
 
 Implanted contraceptive device (hormone implants, intrauterine coil)  ______ 
 
 Oral contraceptive pill and have not missed a pill in the last month _______ 
 
Have you had your womb removed or have been sterilised?_______ 
 
Are you no longer having periods (post menopausal at least 2 years)? ______ 
 
Have you had sexual intercourse since your last period? _______ 
 
Your period is late but you had a negative pregnancy test today _______ 
 
  Pregnancy test result ____________  
 
Signature of staff  __________________  
 
I am very unlikely to be pregnant due one or some of the above reasons. I understand 
that there are risks to an unborn child if I have a radiation test when pregnant 
 
I consent to the examination being performed 
 
Date ___________________ Signature of patient _______________________ 
     
Print name     _______________________ 
 
